Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q41591689
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241120235752.0 |
008
|
|
|
241120nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q41591689
|
024
|
|
|
‡a
0000-0002-0387-880X
‡2
orcid
|
024
|
|
|
‡a
36078972900
‡2
scopus
|
024
|
|
|
‡a
56489064900
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q41591689
|
046
|
|
|
‡f
19600000
|
100
|
0 |
|
‡a
بيتر بي. جونز
‡9
ar
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
Peter B. Jones
‡9
es
‡9
sl
‡9
ast
|
400
|
0 |
|
‡a
পিটার বি. জোন্স
‡c
গবেষক
‡9
bn
|
400
|
0 |
|
‡a
Peter B. Jones
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Peter B. Jones
‡c
onderzoeker
‡9
nl
|
670
|
|
|
‡a
Author's 5-HTTLPR and early childhood adversities moderate cognitive and emotional processing in adolescence
|
670
|
|
|
‡a
Author's A class-contrastive human-interpretable machine learning approach to predict mortality in severe mental illness
|
670
|
|
|
‡a
Author's A comparison of clinical and research DSM-III-R diagnoses of schizophrenia in a Finnish national birth cohort. Clinical and research diagnoses of schizophrenia
|
670
|
|
|
‡a
Author's A Computational Analysis of Abnormal Belief Updating Processes and Their Association With Psychotic Experiences and Childhood Trauma in a UK Birth Cohort
|
670
|
|
|
‡a
Author's A longitudinal typology of symptoms of depression and anxiety over the life course
|
670
|
|
|
‡a
Author's A novel Alzheimer disease locus located near the gene encoding tau protein.
|
670
|
|
|
‡a
Author's A population-based longitudinal study of childhood neurodevelopmental disorders, IQ and subsequent risk of psychotic experiences in adolescence
|
670
|
|
|
‡a
Author's A population-based prospective birth cohort study of childhood neurocognitive and psychological functioning in healthy survivors of early life meningitis
|
670
|
|
|
‡a
Author's A population-based study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence
|
670
|
|
|
‡a
Author's A population-based study of genetic variation and psychotic experiences in adolescents
|
670
|
|
|
‡a
Author's A population-level prediction tool for the incidence of first-episode psychosis: translational epidemiology based on cross-sectional data
|
670
|
|
|
‡a
Author's A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia.
|
670
|
|
|
‡a
Author's A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapine
|
670
|
|
|
‡a
Author's Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis.
|
670
|
|
|
‡a
Author's Acute and transient psychotic disorders: precursors, epidemiology, course and outcome.
|
670
|
|
|
‡a
Author's Administrative incidence of psychosis assessed in an early intervention service in England: first epidemiological evidence from a diverse, rural and urban setting.
|
670
|
|
|
‡a
Author's Adolescence is associated with genomically patterned consolidation of the hubs of the human brain connectome
|
670
|
|
|
‡a
Author's Adolescent friendships predict later resilient functioning across psychosocial domains in a healthy community cohort
|
670
|
|
|
‡a
Author's Adolescent self-control predicts midlife hallucinatory experiences: 40-year follow-up of a national birth cohort
|
670
|
|
|
‡a
Author's Adolescent self-organization predicts midlife memory in a prospective birth cohort study
|
670
|
|
|
‡a
Author's Aggressive behaviour at first contact with services: findings from the AESOP First Episode Psychosis Study.
|
670
|
|
|
‡a
Author's Aggressive incidents in first-episode psychosis.
|
670
|
|
|
‡a
Author's Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors.
|
670
|
|
|
‡a
Author's Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophrenia
|
670
|
|
|
‡a
Author's Appraisals of stressors and common mental disorder from early to mid-adulthood in the 1946 British birth cohort
|
670
|
|
|
‡a
Author's Assessment of posttraumatic symptoms in patients with first-episode psychosis
|
670
|
|
|
‡a
Author's Assessment of remission in schizophrenia with the CGI and CGI-SCH scales
|
670
|
|
|
‡a
Author's Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up
|
670
|
|
|
‡a
Author's Association between common early-childhood infection and subsequent depressive symptoms and psychotic experiences in adolescence: a population-based longitudinal birth cohort study
|
670
|
|
|
‡a
Author's Association between developmental milestones and age of schizophrenia onset: Results from the Northern Finland Birth Cohort 1966
|
670
|
|
|
‡a
Author's Association between duration of untreated psychosis and brain morphology in schizophrenia within the Northern Finland 1966 Birth Cohort.
|
670
|
|
|
‡a
Author's Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review
|
670
|
|
|
‡a
Author's Association between serum C-reactive protein and DSM-IV generalized anxiety disorder in adolescence: Findings from the ALSPAC cohort.
|
670
|
|
|
‡a
Author's Association of cannabis use with prodromal symptoms of psychosis in adolescence
|
670
|
|
|
‡a
Author's Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls
|
670
|
|
|
‡a
Author's Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study
|
670
|
|
|
‡a
Author's Associations between early development and outcome in schizophrenia — A 35-year follow-up of the Northern Finland 1966 Birth Cohort
|
670
|
|
|
‡a
Author's Authors' reply
|
670
|
|
|
‡a
Author's Author's Reply. RE: Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study
|
670
|
|
|
‡a
Author's Autoimmune diseases in the pedigrees of schizophrenic and control subjects
|
670
|
|
|
‡a
Author's Bilateral hippocampal increase following first-episode psychosis is associated with good clinical, functional and cognitive outcomes
|
670
|
|
|
‡a
Author's Biological and psychosocial risk factors for psychotic major depression.
|
670
|
|
|
‡a
Author's Birth cohort studies in psychiatry: beginning at the beginning
|
670
|
|
|
‡a
Author's Birth order and risk for schizophrenia: a 31-year follow-up of the Northern Finland 1966 Birth Cohort
|
670
|
|
|
‡a
Author's Brain-behaviour modes of covariation in healthy and clinically depressed young people
|
670
|
|
|
‡a
Author's Brain micro-architecture and disinhibition: a latent phenotyping study across 33 impulsive and compulsive behaviours
|
670
|
|
|
‡a
Author's Brain structure in different psychosis risk groups in the Northern Finland 1986 Birth Cohort
|
670
|
|
|
‡a
Author's Breaking the web: life beyond the at-risk mental state for psychosis
|
670
|
|
|
‡a
Author's Cannabis and acute psychosis.
|
670
|
|
|
‡a
Author's Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales
|
670
|
|
|
‡a
Author's Cannabis use and outcome of recent onset psychosis
|
670
|
|
|
‡a
Author's Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
|
670
|
|
|
‡a
Author's Cannabis use, gender and age of onset of schizophrenia: data from the ÆSOP study
|
670
|
|
|
‡a
Author's Cannabis use is associated with increased CCL11 plasma levels in young healthy volunteers
|
670
|
|
|
‡a
Author's Caregiving in first-episode psychosis: social characteristics associated with perceived ‘burden’ and associations with compulsory treatment
|
670
|
|
|
‡a
Author's Changes in verbal learning and memory in schizophrenia and non-psychotic controls in midlife: A nine-year follow-up in the Northern Finland Birth Cohort study 1966.
|
670
|
|
|
‡a
Author's Child development risk factors for adult schizophrenia in the British 1946 birth cohort
|
670
|
|
|
‡a
Author's Childhood adversity subtypes and depressive symptoms in early and late adolescence
|
670
|
|
|
‡a
Author's Childhood central nervous system infections and risk for schizophrenia
|
670
|
|
|
‡a
Author's Childhood cognitive ability and adult mental health in the British 1946 birth cohort
|
670
|
|
|
‡a
Author's Childhood cognitive function and adult psychopathology: associations with psychotic and non-psychotic symptoms in the general population
|
670
|
|
|
‡a
Author's Childhood Epstein-Barr Virus infection and subsequent risk of psychotic experiences in adolescence: a population-based prospective serological study
|
670
|
|
|
‡a
Author's Childhood infection and adult schizophrenia: a meta-analysis of population-based studies
|
670
|
|
|
‡a
Author's Childhood laterality and later risk of schizophrenia in the 1946 British birth cohort
|
670
|
|
|
‡a
Author's Childhood schizotypy and positive symptoms in schizophrenic patients predict schizotypy in relatives
|
670
|
|
|
‡a
Author's Childhood trauma and cognitive function in first-episode affective and non-affective psychosis
|
670
|
|
|
‡a
Author's Clinical and social determinants of duration of untreated psychosis in the AESOP first-episode psychosis study.
|
670
|
|
|
‡a
Author's Clinical and sociodemographic comparison of people at high-risk for psychosis and with first-episode psychosis
|
670
|
|
|
‡a
Author's Cognitive behaviour therapy for improving social recovery in psychosis: Cost-effectiveness analysis
|
670
|
|
|
‡a
Author's Cognitive effects of genetic variation in monoamine neurotransmitter systems: a population-based study of COMT, MAOA, and 5HTTLPR.
|
670
|
|
|
‡a
Author's Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings
|
670
|
|
|
‡a
Author's Cognitive reserve in neuropsychiatry.
|
670
|
|
|
‡a
Author's Cohort profile: mental health following extreme trauma in a northern Ugandan cohort of War-Affected Youth Study
|
670
|
|
|
‡a
Author's Cohort profile: mental health following extreme trauma in a northern Ugandan cohort of War-Affected Youth Study (The WAYS Study).
|
670
|
|
|
‡a
Author's Cohort profile: risk patterns and processes for psychopathology emerging during adolescence: the ROOTS project
|
670
|
|
|
‡a
Author's Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11?
|
670
|
|
|
‡a
Author's Commentary on: Mendelson T & Eaton WW. Recent advances in the prevention of mental disorders. SPPE
|
670
|
|
|
‡a
Author's Commentary on: Mendelson T & Eaton WW. Recent advances in the prevention of mental disorders. SPPE (2018)
|
670
|
|
|
‡a
Author's Common versus psychopathology-specific risk factors for psychotic experiences and depression during adolescence
|
670
|
|
|
‡a
Author's Comparative effectiveness of cognitive therapies delivered face-to-face or over the telephone: an observational study using propensity methods
|
670
|
|
|
‡a
Author's Comparing time use in individuals at different stages of psychosis and a non-clinical comparison group
|
670
|
|
|
‡a
Author's Comparison of high and low intensity contact between secondary and primary care to detect people at ultra-high risk for psychosis: study protocol for a theory-based, cluster randomized controlled trial
|
670
|
|
|
‡a
Author's Compulsivity and impulsivity traits linked to attenuated developmental frontostriatal myelination trajectories
|
670
|
|
|
‡a
Author's Correction: Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort
|
670
|
|
|
‡a
Author's Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy.
|
670
|
|
|
‡a
Author's Cost of improving Access to Psychological Therapies (IAPT) programme: an analysis of cost of session, treatment and recovery in selected Primary Care Trusts in the East of England region
|
670
|
|
|
‡a
Author's Criminal offending and distinguishing features of offenders among persons experiencing a first episode of psychosis
|
670
|
|
|
‡a
Author's Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes
|
670
|
|
|
‡a
Author's Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study
|
670
|
|
|
‡a
Author's Cultural differences in pathways to care, service use and treated outcomes
|
670
|
|
|
‡a
Author's Cumulative social disadvantage, ethnicity and first-episode psychosis: a case-control study
|
670
|
|
|
‡a
Author's Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study
|
670
|
|
|
‡a
Author's Default mode network in young people with familial risk for psychosis--the Oulu Brain and Mind study
|
670
|
|
|
‡a
Author's Defining the needs of patients with intellectual disabilities in the high security psychiatric hospitals in England.
|
670
|
|
|
‡a
Author's Depressive symptoms during adolescence: comparison between epidemiological and high risk sampling
|
670
|
|
|
‡a
Author's Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule
|
670
|
|
|
‡a
Author's Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule (NOS).
|
670
|
|
|
‡a
Author's Developmental cognitive neuroscience using latent change score models: A tutorial and applications.
|
670
|
|
|
‡a
Author's Developmental typology of trajectories to nighttime bladder control: epidemiologic application of longitudinal latent class analysis
|
670
|
|
|
‡a
Author's Deviant intrauterine growth and risk of schizophrenia: a 34-year follow-up of the Northern Finland 1966 Birth Cohort
|
670
|
|
|
‡a
Author's Diagnostic change 10 years after a first episode of psychosis
|
670
|
|
|
‡a
Author's Diagnostic stability and outcome after first episode psychosis
|
670
|
|
|
‡a
Author's Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study
|
670
|
|
|
‡a
Author's Different vulnerability indicators for psychosis and their neuropsychological characteristics in the Northern Finland 1986 Birth Cohort
|
670
|
|
|
‡a
Author's Differential relationship between neurological and cognitive dysfunction in first episode psychosis patients and in healthy individuals
|
670
|
|
|
‡a
Author's Differing patterns of brain structural abnormalities between black and white patients with their first episode of psychosis
|
670
|
|
|
‡a
Author's Discharged from special hospital under restrictions: a comparison of the fates of psychopaths and the mentally ill
|
670
|
|
|
‡a
Author's Disease-relevant autoantibodies in first episode schizophrenia
|
670
|
|
|
‡a
Author's Do obstetric complications cause the earlier age at onset in male than female schizophrenics?
|
670
|
|
|
‡a
Author's Does maternal body mass index during pregnancy influence risk of schizophrenia in the adult offspring?
|
670
|
|
|
‡a
Author's Duration of prodromal phase and severity of volumetric abnormalities in first-episode psychosis
|
670
|
|
|
‡a
Author's Duration of untreated psychosis and ethnicity in the AESOP first-onset psychosis study
|
670
|
|
|
‡a
Author's Duration of untreated psychosis and neuropsychological function in first episode psychosis.
|
670
|
|
|
‡a
Author's Early detection and intervention evaluation for people at high-risk of psychosis-2 (EDIE-2): trial rationale, design and baseline characteristics.
|
670
|
|
|
‡a
Author's Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial.
|
670
|
|
|
‡a
Author's Early development, stress and depression across the life course: pathways to depression in a national British birth cohort
|
670
|
|
|
‡a
Author's Early intervention for incipient insanity: early notions from the 19(th) century English literature.
|
670
|
|
|
‡a
Author's Early intervention in psychosis: keeping the body in mind
|
670
|
|
|
‡a
Author's Early intervention services in psychosis: from evidence to wide implementation.
|
670
|
|
|
‡a
Author's Early risk factors and adult person--environment relationships in affective disorder.
|
670
|
|
|
‡a
Author's Early risk factors for suicide in an epidemiological first episode psychosis cohort
|
670
|
|
|
‡a
Author's Early sustained recovery following first episode psychosis: Evidence from the AESOP10 follow-up study.
|
670
|
|
|
‡a
Author's Educational consequences of mental disorders treated in hospital. A 31-year follow-up of the Northern Finland 1966 Birth Cohort.
|
670
|
|
|
‡a
Author's Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes: a longitudinal analysis and modelling study
|
670
|
|
|
‡a
Author's Effect of prior treatment with antipsychotic long-acting injection on randomised clinical trial treatment outcomes
|
670
|
|
|
‡a
Author's Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes
|
670
|
|
|
‡a
Author's Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study
|
670
|
|
|
‡a
Author's Effects of cannabis use on outcomes of psychotic disorders: systematic review
|
670
|
|
|
‡a
Author's Effects of catechol-O-methyltransferase on normal variation in the cognitive function of children
|
670
|
|
|
‡a
Author's Effects of modafinil on cognitive functions in first episode psychosis
|
670
|
|
|
‡a
Author's Effects of modafinil on emotional processing in first episode psychosis
|
670
|
|
|
‡a
Author's Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls
|
670
|
|
|
‡a
Author's Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms
|
670
|
|
|
‡a
Author's Epidemiological aspects of migration and mental illness
|
670
|
|
|
‡a
Author's Epidemiological challenges in systematic reviews
|
670
|
|
|
‡a
Author's Establishing a Theory-Based Multi-Level Approach for Primary Prevention of Mental Disorders in Young People
|
670
|
|
|
‡a
Author's Ethnic identity, perceptions of disadvantage, and psychosis: findings from the ÆSOP study
|
670
|
|
|
‡a
Author's Ethnicity and mental health: the example of schizophrenia and related psychoses in migrant populations in the Western world
|
670
|
|
|
‡a
Author's Ethnicity and mental health: the example of schizophrenia in migrant populations across Europe
|
670
|
|
|
‡a
Author's Ethnicity and Mental Health: The Example of Schizophrenia in the African-Caribbean Population in Europe
|
670
|
|
|
‡a
Author's Ethnicity, social disadvantage and psychotic-like experiences in a healthy population based sample
|
670
|
|
|
‡a
Author's Examining evidence for neighbourhood variation in the duration of untreated psychosis.
|
670
|
|
|
‡a
Author's Examining pathways between genetic liability for schizophrenia and patterns of tobacco and cannabis use in adolescence
|
670
|
|
|
‡a
Author's Exercise and depressive symptoms in adolescents: a longitudinal cohort study
|
670
|
|
|
‡a
Author's Explaining sex differences in course and outcome in the functional psychoses
|
670
|
|
|
‡a
Author's Expressed emotion: relevance to rehospitalization in schizophrenia over 7 years
|
670
|
|
|
‡a
Author's Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs
|
670
|
|
|
‡a
Author's Factors associated with antidepressant, anxiolytic and hypnotic use over 17 years in a national cohort
|
670
|
|
|
‡a
Author's Family history of autoimmune diseases in psychosis
|
670
|
|
|
‡a
Author's First- vs Second-Generation Antipsychotic Drugs in Schizophrenia—Reply
|
670
|
|
|
‡a
Author's Forty-year psychiatric outcomes following assessment for internalizing disorder in adolescence.
|
670
|
|
|
‡a
Author's Friendships and Family Support Reduce Subsequent Depressive Symptoms in At-Risk Adolescents
|
670
|
|
|
‡a
Author's Fronto-cerebellar systems are associated with infant motor and adult executive functions in healthy adults but not in schizophrenia
|
670
|
|
|
‡a
Author's Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis
|
670
|
|
|
‡a
Author's Functional mapping of dynamic happy and fearful facial expressions in young adults with familial risk for psychosis - Oulu Brain and Mind Study
|
670
|
|
|
‡a
Author's Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England.
|
670
|
|
|
‡a
Author's Gender differences in neuropsychological performance across psychotic disorders--a multi-centre population based case-control study
|
670
|
|
|
‡a
Author's Gender differences in the association between childhood abuse and psychosis.
|
670
|
|
|
‡a
Author's Gender differences in the association between childhood physical and sexual abuse, social support and psychosis
|
670
|
|
|
‡a
Author's Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children
|
670
|
|
|
‡a
Author's Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22.
|
670
|
|
|
‡a
Author's General distress, hopelessness-suicidal ideation and worrying in adolescence: concurrent and predictive validity of a symptom-level bifactor model for clinical diagnoses.
|
670
|
|
|
‡a
Author's Genes and the social environment
|
670
|
|
|
‡a
Author's Genes, viruses and neurodevelopmental schizophrenia
|
670
|
|
|
‡a
Author's Global population attributable fraction of potentially modifiable risk factors for mental disorders: a meta-umbrella systematic review
|
670
|
|
|
‡a
Author's Gray matter abnormalities associated with duration of untreated psychosis
|
670
|
|
|
‡a
Author's Grey matter abnormalities in first-episode schizophrenia and affective psychosis
|
670
|
|
|
‡a
Author's Grey matter correlates of minor physical anomalies in the AeSOP first-episode psychosis study
|
670
|
|
|
‡a
Author's Heterogeneity in Incidence Rates of Schizophrenia and Other Psychotic Syndromes
|
670
|
|
|
‡a
Author's Hippocampus and amygdala volumes in schizophrenia and other psychoses in the Northern Finland 1966 birth cohort
|
670
|
|
|
‡a
Author's Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations
|
670
|
|
|
‡a
Author's If cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations
|
670
|
|
|
‡a
Author's Illicit substance use and its correlates in first episode psychosis
|
670
|
|
|
‡a
Author's Immune dysregulation among students exposed to exam stress and its mitigation by mindfulness training: findings from an exploratory randomised trial
|
670
|
|
|
‡a
Author's Immunotherapy for patients with acute psychosis and serum N-Methyl D-Aspartate receptor (NMDAR) antibodies: a description of a treated case series
|
670
|
|
|
‡a
Author's Impact of cognitive therapy on internalised stigma in people with at-risk mental states
|
670
|
|
|
‡a
Author's Impact of early intervention services on duration of untreated psychosis: data from the National EDEN prospective cohort study
|
670
|
|
|
‡a
Author's Improved quality of life over one year is associated with improved adherence in patients with schizophrenia.
|
670
|
|
|
‡a
Author's Improvement and decline of cognitive function in schizophrenia over one year: a longitudinal investigation using latent growth modelling
|
670
|
|
|
‡a
Author's Improving access to psychological therapies and older people: findings from the Eastern Region
|
670
|
|
|
‡a
Author's Incentive motivation in first-episode psychosis: a behavioural study
|
670
|
|
|
‡a
Author's Incidence and distribution of first-episode mania by age: results from a 35-year study.
|
670
|
|
|
‡a
Author's Incidence of bipolar affective disorder in three UK cities: results from the AESOP study.
|
670
|
|
|
‡a
Author's Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses
|
670
|
|
|
‡a
Author's Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study
|
670
|
|
|
‡a
Author's Increased incidence of psychotic disorders in migrants from the Caribbean to the United Kingdom.
|
670
|
|
|
‡a
Author's Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study
|
670
|
|
|
‡a
Author's Increased risk of schizophrenia from additive interaction between infant motor developmental delay and obstetric complications: evidence from a population-based longitudinal study
|
670
|
|
|
‡a
Author's Individualized prediction of illness course at the first psychotic episode: a support vector machine MRI study
|
670
|
|
|
‡a
Author's Infant developmental milestones and subsequent cognitive function
|
670
|
|
|
‡a
Author's Infant motor development and adult cognitive functions in schizophrenia.
|
670
|
|
|
‡a
Author's Infant motor development is associated with adult cognitive categorisation in a longitudinal birth cohort study.
|
670
|
|
|
‡a
Author's Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
|
670
|
|
|
‡a
Author's Insight, grey matter and cognitive function in first-onset psychosis
|
670
|
|
|
‡a
Author's Interaction between parental psychosis and early motor development and the risk of schizophrenia in a general population birth cohort
|
670
|
|
|
‡a
Author's Interplay between childhood physical abuse and familial risk in the onset of psychotic disorders
|
670
|
|
|
‡a
Author's Intrinsic curvature: a marker of millimeter-scale tangential cortico-cortical connectivity?
|
670
|
|
|
‡a
Author's Investigating the genetic architecture of general and specific psychopathology in adolescence
|
670
|
|
|
‡a
Author's IQ in childhood psychiatric attendees predicts outcome of later schizophrenia at 21 year follow-up.
|
670
|
|
|
‡a
Author's Is prematurity associated with adult cognitive outcome and brain structure?
|
670
|
|
|
‡a
Author's Is the incidence of psychotic disorder in decline? Epidemiological evidence from two decades of research
|
670
|
|
|
‡a
Author's Is there a link between childhood trauma, cognition, and amygdala and hippocampus volume in first-episode psychosis?
|
670
|
|
|
‡a
Author's Jumping To Conclusions, General Intelligence, And Psychosis Liability: Findings From The Multicentric EU-GEI Case-Control Study
|
670
|
|
|
‡a
Author's Life events before psychotic episodes: do clinical and social variables affect the relationship?
|
670
|
|
|
‡a
Author's Life mapping: a 'Therapeutic Document' approach to needs assessment
|
670
|
|
|
‡a
Author's Lifetime affect and midlife cognitive function: prospective birth cohort study
|
670
|
|
|
‡a
Author's Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia - An observational 9-year follow-up study
|
670
|
|
|
‡a
Author's Lifetime use of psychiatric medications and cognition at 43years of age in schizophrenia in the Northern Finland Birth Cohort 1966.
|
670
|
|
|
‡a
Author's Linear and non-linear associations of symptom dimensions and cognitive function in first-onset psychosis
|
670
|
|
|
‡a
Author's Linking the developmental and degenerative theories of schizophrenia: association between infant development and adult cognitive decline
|
670
|
|
|
‡a
Author's Links between creativity and mental disorder
|
670
|
|
|
‡a
Author's Lithium in bipolar and other affective disorders: prescribing practice in the UK.
|
670
|
|
|
‡a
Author's Lithium is more effective than placebo for preventing all relapses in patients with bipolar but not unipolar disorder
|
670
|
|
|
‡a
Author's Longitudinal associations between childhood and adulthood externalizing and internalizing psychopathology and adolescent substance use.
|
670
|
|
|
‡a
Author's Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication
|
670
|
|
|
‡a
Author's Longitudinal population subgroups of CRP and risk of depression in the ALSPAC birth cohort
|
670
|
|
|
‡a
Author's Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function
|
670
|
|
|
‡a
Author's Lower prevalence of pre-morbid neurological illness in African-Caribbean than White psychotic patients in England.
|
670
|
|
|
‡a
Author's Maternal separation at birth and schizophrenia—a long-term follow-up of the Finnish Christmas Seal Home Children
|
670
|
|
|
‡a
Author's Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D.
|
670
|
|
|
‡a
Author's Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
|
670
|
|
|
‡a
Author's Meta-analytic approaches to determine gender differences in the age-incidence characteristics of schizophrenia and related psychoses
|
670
|
|
|
‡a
Author's Migration and mental illness
|
670
|
|
|
‡a
Author's Mindfulness-based programmes for mental health promotion in adults in non-clinical settings: protocol of an individual participant data meta-analysis of randomised controlled trials
|
670
|
|
|
‡a
Author's Minocycline for negative symptoms of schizophrenia and possible mechanistic actions: the BeneMin RCT
|
670
|
|
|
‡a
Author's Minor physical anomalies across ethnic groups in a first episode psychosis sample
|
670
|
|
|
‡a
Author's Minor physical anomalies in patients with first-episode psychosis: their frequency and diagnostic specificity.
|
670
|
|
|
‡a
Author's Minor physical anomalies in psychoses: associations with clinical and putative aetiological variables
|
670
|
|
|
‡a
Author's Minor physical anomalies in schizophrenia: is age a confounding factor?
|
670
|
|
|
‡a
Author's Modafinil effects on cognition and emotion in schizophrenia and its neurochemical modulation in the brain
|
670
|
|
|
‡a
Author's Modelling the interplay between childhood and adult adversity in pathways to psychosis: initial evidence from the AESOP study
|
670
|
|
|
‡a
Author's Mokken scale analysis of mental health and well-being questionnaire item responses: a non-parametric IRT method in empirical research for applied health researchers
|
670
|
|
|
‡a
Author's Mood, anxiety and psychotic phenomena measure a common psychopathological factor
|
670
|
|
|
‡a
Author's Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis
|
670
|
|
|
‡a
Author's Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness
|
670
|
|
|
‡a
Author's Mortality in first-contact psychosis patients in the U.K.: a cohort study.
|
670
|
|
|
‡a
Author's Motor co-ordination deficits as predictors of schizophrenia among Finnish school children
|
670
|
|
|
‡a
Author's Multilevel investigation of variation in HoNOS ratings by mental health professionals: a naturalistic study of consecutive referrals.
|
670
|
|
|
‡a
Author's Multilevel ordinal factor analysis of the positive and negative syndrome scale
|
670
|
|
|
‡a
Author's Multilevel ordinal factor analysis of the positive and negative syndrome scale (PANSS).
|
670
|
|
|
‡a
Author's Negative cognition, affect, metacognition and dimensions of paranoia in people at ultra-high risk of psychosis: a multi-level modelling analysis.
|
670
|
|
|
‡a
Author's Neighbourhood-level effects on psychoses: re-examining the role of context
|
670
|
|
|
‡a
Author's Neighbourhood variation in the incidence of psychotic disorders in Southeast London
|
670
|
|
|
‡a
Author's Neuregulin-1 genotype is associated with structural differences in the normal human brain
|
670
|
|
|
‡a
Author's Neurocomputational mechanisms underpinning aberrant social learning in young adults with low self-esteem
|
670
|
|
|
‡a
Author's Neurological abnormalities and cognitive ability in first-episode psychosis.
|
670
|
|
|
‡a
Author's Neuropsychological functioning in first-episode schizophrenia
|
670
|
|
|
‡a
Author's Neuroticism as a risk factor for schizophrenia
|
670
|
|
|
‡a
Author's No association between breast-feeding and adult psychosis in two national birth cohorts
|
670
|
|
|
‡a
Author's No association of COMT (Val158Met) genotype with brain structure differences between men and women
|
670
|
|
|
‡a
Author's Non-linear relationship between an index of social deprivation, psychiatric admission prevalence and the incidence of psychosis
|
670
|
|
|
‡a
Author's Non-neurological and metabolic side effects in the Cost Utility of the Latest Antipsychotics in Schizophrenia Randomised Controlled Trial
|
670
|
|
|
‡a
Author's Non-neurological and metabolic side effects in the Cost Utility of the Latest Antipsychotics in Schizophrenia Randomised Controlled Trial (CUtLASS-1).
|
670
|
|
|
‡a
Author's Obstetric complications and familial morbid risk of psychiatric disorders
|
670
|
|
|
‡a
Author's Obstetric complications and schizophrenia: historical and meta-analytic review
|
670
|
|
|
‡a
Author's Oligodendrocyte dysfunction in schizophrenia and bipolar disorder
|
670
|
|
|
‡a
Author's Onset-age of bipolar disorders at six international sites
|
670
|
|
|
‡a
Author's Outcome and its predictors in schizophrenia within the Northern Finland 1966 Birth Cohort
|
670
|
|
|
‡a
Author's Outcomes of conduct problems in adolescence: 40 year follow-up of national cohort
|
670
|
|
|
‡a
Author's Parental separation, loss and psychosis in different ethnic groups: a case-control study
|
670
|
|
|
‡a
Author's Parity of esteem begins at home: translating empirical psychiatric research into effective public mental health.
|
670
|
|
|
‡a
Author's Pathways to care and ethnicity. 1: Sample characteristics and compulsory admission. Report from the AESOP study
|
670
|
|
|
‡a
Author's Pathways to care and ethnicity. 2: Source of referral and help-seeking. Report from the AESOP study
|
670
|
|
|
‡a
Author's Pathways to violent behavior during first-episode psychosis: a report from the UK National EDEN Study
|
670
|
|
|
‡a
Author's Perceptions of disadvantage, ethnicity and psychosis
|
670
|
|
|
‡a
Author's Perinatal and childhood risk factors for later criminality and violence in schizophrenia. Longitudinal, population-based study
|
670
|
|
|
‡a
Author's Personality disorder in an Early Intervention Psychosis cohort: Findings from the Social Epidemiology of Psychoses in East Anglia (SEPEA) study
|
670
|
|
|
‡a
Author's Phenotypic Manifestation of Genetic Risk for Schizophrenia During Adolescence in the General Population
|
670
|
|
|
‡a
Author's Poor premorbid school performance, but not severity of illness, predicts cognitive decline in schizophrenia in midlife
|
670
|
|
|
‡a
Author's Postwar environment and long-term mental health problems in former child soldiers in Northern Uganda: the WAYS study
|
670
|
|
|
‡a
Author's Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom
|
670
|
|
|
‡a
Author's Pre-morbid fertility in psychosis: findings from the AESOP first episode study
|
670
|
|
|
‡a
Author's Pre-training inter-rater reliability of clinical instruments in an international psychosis research project
|
670
|
|
|
‡a
Author's Precursors and correlates of transient and persistent longitudinal profiles of psychotic experiences from late childhood through early adulthood
|
670
|
|
|
‡a
Author's Predictors of later schizophrenia and affective psychosis among attendees at a child psychiatry department.
|
670
|
|
|
‡a
Author's Predictors of schizophrenia--a review
|
670
|
|
|
‡a
Author's Prenatal maternal influenza and schizophrenia in offspring: What does this tell us about fetal programming of chronic disease?
|
670
|
|
|
‡a
Author's Prevalence and correlates of low-grade systemic inflammation in adult psychiatric inpatients: An electronic health record-based study.
|
670
|
|
|
‡a
Author's Prevalence of depression in older people in England and Wales: the MRC CFA Study
|
670
|
|
|
‡a
Author's Profiles of family-focused adverse experiences through childhood and early adolescence: the ROOTS project a community investigation of adolescent mental health
|
670
|
|
|
‡a
Author's Prospective cohort study of mental health during imprisonment
|
670
|
|
|
‡a
Author's Psychiatric morbidity, functioning and quality of life in young people at clinical high risk for psychosis
|
670
|
|
|
‡a
Author's Psychiatric outcomes 10 years after treatment with antidepressants or anxiolytics.
|
670
|
|
|
‡a
Author's Psychoses, ethnicity and socio-economic status.
|
670
|
|
|
‡a
Author's Psychosis incidence through the prism of early intervention services
|
670
|
|
|
‡a
Author's Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study
|
670
|
|
|
‡a
Author's Psychotic symptoms in young people without psychotic illness: mechanisms and meaning
|
670
|
|
|
‡a
Author's Raised incidence rates of all psychoses among migrant groups: findings from the East London first episode psychosis study
|
670
|
|
|
‡a
Author's Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia
|
670
|
|
|
‡a
Author's Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study
|
670
|
|
|
‡a
Author's Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
|
670
|
|
|
‡a
Author's Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study
|
670
|
|
|
‡a
Author's Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 Birth Cohort.
|
670
|
|
|
‡a
Author's Reassessing the long-term risk of suicide after a first episode of psychosis
|
670
|
|
|
‡a
Author's Record linkage of domestic assault victims between an emergency department and the police
|
670
|
|
|
‡a
Author's Reducing duration of untreated psychosis: care pathways to early intervention in psychosis services
|
670
|
|
|
‡a
Author's Reinforcement and reversal learning in first-episode psychosis.
|
670
|
|
|
‡a
Author's Relationship of birth season to clinical features, family history, and obstetric complications in schizophrenia
|
670
|
|
|
‡a
Author's Reliability and comparability of psychosis patients' retrospective reports of childhood abuse
|
670
|
|
|
‡a
Author's Response initiation in young adults at risk for psychosis in the Northern Finland 1986 Birth Cohort
|
670
|
|
|
‡a
Author's Risk factors for onset and persistence of psychosis.
|
670
|
|
|
‡a
Author's Satisfaction with inpatient treatment for first-episode psychosis among different ethnic groups: a report from the UK AeSOP study.
|
670
|
|
|
‡a
Author's Schizophrenia and other psychotic disorders in Caribbean-born migrants and their descendants in England: systematic review and meta-analysis of incidence rates, 1950-2013
|
670
|
|
|
‡a
Author's Schizophrenia in the offspring of antenatally depressed mothers: a 31-year follow-up of the Northern Finland 1966 Birth Cohort
|
670
|
|
|
‡a
Author's Schizophrenia in the Offspring of Antenatally Depressed Mothers in the Northern Finland 1966 Birth Cohort: Relationship to Family History of Psychosis
|
670
|
|
|
‡a
Author's Schizophrenia: social and environmental factors: implications for aetiology
|
670
|
|
|
‡a
Author's Schizophrenia: The Epidemiological Horizon
|
670
|
|
|
‡a
Author's Schizophrenia trial participation: perceived inclusion barriers and beliefs about antipsychotics
|
670
|
|
|
‡a
Author's Schizophrenic patients and their first-degree relatives show an excess of mixed-handedness
|
670
|
|
|
‡a
Author's Schizotypy-related magnetization of cortex in healthy adolescence is co-located with expression of schizophrenia risk genes:
|
670
|
|
|
‡a
Author's School performance as a predictor of psychiatric hospitalization in adult life. A 28-year follow-up in the Northern Finland 1966 Birth Cohort.
|
670
|
|
|
‡a
Author's School performance in Finnish children and later development of schizophrenia: a population-based longitudinal study
|
670
|
|
|
‡a
Author's Selective deficits in semantic verbal fluency in patients with a first affective episode with psychotic symptoms and a positive history of mania
|
670
|
|
|
‡a
Author's Self esteem and self agency in first episode psychosis: Ethnic variation and relationship with clinical presentation
|
670
|
|
|
‡a
Author's Self-harm in first-episode psychosis
|
670
|
|
|
‡a
Author's Serum lipids in schizophrenia and other functional psychoses: a general population northern Finland 1966 birth cohort survey
|
670
|
|
|
‡a
Author's Service users' views of moving on from early intervention services for psychosis: a longitudinal qualitative study in primary care
|
670
|
|
|
‡a
Author's Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort
|
670
|
|
|
‡a
Author's Social deprivation, inequality, and the neighborhood-level incidence of psychotic syndromes in East London
|
670
|
|
|
‡a
Author's Spatial and temporal mapping of neural activity associated with auditory hallucinations
|
670
|
|
|
‡a
Author's Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations
|
670
|
|
|
‡a
Author's Speed of facial affect intensity recognition as an endophenotype of first-episode psychosis and associated limbic-cortical grey matter systems.
|
670
|
|
|
‡a
Author's Sporadic schizophrenia - another male preserve?
|
670
|
|
|
‡a
Author's Stress and development of depression and heavy drinking in adulthood: moderating effects of childhood trauma
|
670
|
|
|
‡a
Author's Structure and function of the corpus callosum in schizophrenia: What's the connection?
|
670
|
|
|
‡a
Author's Substance use in a population-based clinic sample of people with first-episode psychosis
|
670
|
|
|
‡a
Author's Ten-year outcomes in first episode psychotic major depression patients compared with schizophrenia and bipolar patients.
|
670
|
|
|
‡a
Author's Testing the association between the incidence of schizophrenia and social capital in an urban area
|
670
|
|
|
‡a
Author's The antecedents of schizophrenia: a review of birth cohort studies
|
670
|
|
|
‡a
Author's The association between domestic violence and self harm in emergency medicine patients
|
670
|
|
|
‡a
Author's The association between pubertal status and depressive symptoms and diagnoses in adolescent females: A population-based cohort study.
|
670
|
|
|
‡a
Author's The association between substance misuse and first-episode psychosis in a defined UK geographical area during the 1990s
|
670
|
|
|
‡a
Author's The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial
|
670
|
|
|
‡a
Author's The brain structural disposition to social interaction
|
670
|
|
|
‡a
Author's The catechol-O-methyltransferase gene (COMT) and cognitive function from childhood through adolescence
|
670
|
|
|
‡a
Author's The differential effect of illicit drug use on cognitive function in first-episode psychosis and healthy controls
|
670
|
|
|
‡a
Author's The early impact of COVID-19 on mental health and community physical health services and their patients' mortality in Cambridgeshire and Peterborough, UK
|
670
|
|
|
‡a
Author's The economic cost of pathways to care in first episode psychosis
|
670
|
|
|
‡a
Author's The effect of the environment on symptom dimensions in the first episode of psychosis: a multilevel study.
|
670
|
|
|
‡a
Author's The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment
|
670
|
|
|
‡a
Author's The functional anatomy of auditory hallucinations in schizophrenia.
|
670
|
|
|
‡a
Author's The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people
|
670
|
|
|
‡a
Author's The influence of different types of war experiences on depression and anxiety in a Ugandan cohort of war-affected youth: the WAYS study
|
670
|
|
|
‡a
Author's The influence of temperament on symptoms and functional outcome in people with psychosis in the Northern Finland 1966 Birth Cohort.
|
670
|
|
|
‡a
Author's The persistence of developmental markers in childhood and adolescence and risk for schizophrenic psychoses in adult life. A 34-year follow-up of the Northern Finland 1966 birth cohort
|
670
|
|
|
‡a
Author's The prevalence, diagnostic significance and demographic characteristics of Schneiderian first-rank symptoms in an epidemiological sample of first-episode psychoses
|
670
|
|
|
‡a
Author's The Prevention of Schizophrenia--What Can We Learn From Eco-Epidemiology?
|
670
|
|
|
‡a
Author's The progression of disorder-specific brain pattern expression in schizophrenia over 9 years
|
670
|
|
|
‡a
Author's The security, clinical and social needs of patients in high security psychiatric hospitals in England
|
670
|
|
|
‡a
Author's The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study
|
670
|
|
|
‡a
Author's The structural brain correlates of neurological soft signs in healthy individuals
|
670
|
|
|
‡a
Author's The subjective and cognitive effects of acute phenylalanine and tyrosine depletion in patients recovered from depression
|
670
|
|
|
‡a
Author's The UK national evaluation of the development and impact of Early Intervention Services (the National EDEN studies): study rationale, design and baseline characteristics
|
670
|
|
|
‡a
Author's The varying impact of type, timing and frequency of exposure to childhood adversity on its association with adult psychotic disorder.
|
670
|
|
|
‡a
Author's Three decades of antidepressant, anxiolytic and hypnotic use in a national population birth cohort
|
670
|
|
|
‡a
Author's Three-year outcome of first-episode psychoses in an established community psychiatric service.
|
670
|
|
|
‡a
Author's Translating the epidemiology of psychosis into public mental health: evidence, challenges and future prospects
|
670
|
|
|
‡a
Author's Trauma exposure, PTSD and psychotic-like symptoms in post-conflict Timor Leste: an epidemiological survey
|
670
|
|
|
‡a
Author's Trauma history characteristics associated with mental states at clinical high risk for psychosis
|
670
|
|
|
‡a
Author's Unemployment, social isolation, achievement-expectation mismatch and psychosis: findings from the AESOP Study
|
670
|
|
|
‡a
Author's Use of the theory of planned behaviour to assess factors influencing the identification of individuals at ultra-high risk for psychosis in primary care
|
670
|
|
|
‡a
Author's Usefulness of EQ-5D for evaluation of health-related quality of life in young adults with first-episode psychosis
|
670
|
|
|
‡a
Author's Verbal fluency in patients with schizophrenia and affective psychoses and their first-degree relatives
|
670
|
|
|
‡a
Author's Views of Young People in Early Intervention Services for First-Episode Psychosis in England
|
670
|
|
|
‡a
Author's Visuospatial learning and executive function are independently impaired in first-episode psychosis.
|
670
|
|
|
‡a
Author's Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study
|
670
|
|
|
‡a
Author's Volumes of brain, grey and white matter and cerebrospinal fluid in schizophrenia in the Northern Finland 1966 Birth Cohort: an epidemiological approach to analysis
|
670
|
|
|
‡a
Author's War experiences, general functioning and barriers to care among former child soldiers in Northern Uganda: the WAYS study
|
670
|
|
|
‡a
Author's Which characteristics of schizophrenia predate psychosis?
|
670
|
|
|
‡a
Author's White matter structure in young adults with familial risk for psychosis - The Oulu Brain and Mind Study
|
670
|
|
|
‡a
Author's Why psychiatry can't afford to be neurophobic
|
670
|
|
|
‡a
Author's Young people at risk for psychosis: case finding and sample characteristics of the Oulu Brain and Mind Study
|
670
|
|
|
‡a
Author's Young people's views of UK mental health services
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/GRATEVE|275031
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/DNB|1011623552
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/NUKAT|n 2007133076
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/ISNI|0000000119535791
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/viaf/102237327
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/LC|no2003084028
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/SUDOC|070986185
|
909
|
|
|
‡a
(orcid) 000000020387880x
‡9
1
|
909
|
|
|
‡a
(scopus) 36078972900
‡9
1
|
909
|
|
|
‡a
(scopus) 56489064900
‡9
1
|
912
|
|
|
‡a
novelalzheimerdiseaselocuslocatednearthegeneencodingtauprotein
‡A
A novel Alzheimer disease locus located near the gene encoding tau protein.
‡9
1
|
912
|
|
|
‡a
authorsreply
‡A
Authors' reply
‡9
1
|
912
|
|
|
‡a
cognitivefunctioningthroughoutadulthoodandillnessstagesinindividualswithpsychoticdisordersandtheirunaffectedsiblings
‡A
Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings
‡9
1
|
912
|
|
|
‡a
identifyinggeneenvironmentinteractionsinschizophreniacontemporarychallengesforintegratedlargescaleinvestigations
‡A
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations
‡9
1
|
912
|
|
|
‡a
metaanalysisof74046individualsidentifies11newsusceptibilitylociforalzheimersdisease
‡A
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
‡9
1
|
919
|
|
|
‡a
commentaryonmendelsontandeatonwwrecentadvancesinthepreventionofmentaldisorderssppe
‡A
Commentary on: Mendelson T & Eaton WW. Recent advances in the prevention of mental disorders. SPPE
‡9
2
|
919
|
|
|
‡a
uknationalevaluationofthedevelopmentandimpactofearlyinterventionservicesthenationaledenstudiesstudyrationaledesignandbaselinecharacteristics
‡A
The UK national evaluation of the development and impact of Early Intervention Services (the National EDEN studies): study rationale, design and baseline characteristics
‡9
1
|
919
|
|
|
‡a
varyingimpactoftypetimingandfrequencyofexposuretochildhoodadversityonitsassociationwithadultpsychoticdisorder
‡A
The varying impact of type, timing and frequency of exposure to childhood adversity on its association with adult psychotic disorder.
‡9
1
|
919
|
|
|
‡a
3decadesofantidepressantanxiolyticandhypnoticuseinanationalpopulationbirthcohort
‡A
Three decades of antidepressant, anxiolytic and hypnotic use in a national population birth cohort
‡9
1
|
919
|
|
|
‡a
3yearoutcomeof1episodepsychosesinanestablishedcommunitypsychiatricservice
‡A
Three-year outcome of first-episode psychoses in an established community psychiatric service.
‡9
1
|
919
|
|
|
‡a
translatingtheepidemiologyofpsychosisintopublicmentalhealthevidencechallengesandfutureprospects
‡A
Translating the epidemiology of psychosis into public mental health: evidence, challenges and future prospects
‡9
1
|
919
|
|
|
‡a
traumaexposureptsdandpsychoticlikesymptomsinpostconflicttimorlesteanepidemiologicalsurvey
‡A
Trauma exposure, PTSD and psychotic-like symptoms in post-conflict Timor Leste: an epidemiological survey
‡9
1
|
919
|
|
|
‡a
traumahistorycharacteristicsassociatedwithmentalstatesatclinicalhighriskforpsychosis
‡A
Trauma history characteristics associated with mental states at clinical high risk for psychosis
‡9
1
|
919
|
|
|
‡a
unemploymentsocialisolationachievementexpectationmismatchandpsychosisfindingsfromtheaesopstudy
‡A
Unemployment, social isolation, achievement-expectation mismatch and psychosis: findings from the AESOP Study
‡9
1
|
919
|
|
|
‡a
useofthetheoryofplannedbehaviourtoassessfactorsinfluencingtheidentificationofindividualsatultrahighriskforpsychosisinprimarycare
‡A
Use of the theory of planned behaviour to assess factors influencing the identification of individuals at ultra-high risk for psychosis in primary care
‡9
1
|
919
|
|
|
‡a
usefulnessofeq5dforevaluationofhealthrelatedqualityoflifeinyoungadultswith1episodepsychosis
‡A
Usefulness of EQ-5D for evaluation of health-related quality of life in young adults with first-episode psychosis
‡9
1
|
919
|
|
|
‡a
verbalfluencyinpatientswithschizophreniaandaffectivepsychosesandtheir1degreerelatives
‡A
Verbal fluency in patients with schizophrenia and affective psychoses and their first-degree relatives
‡9
1
|
919
|
|
|
‡a
viewsofyoungpeopleinearlyinterventionservicesfor1episodepsychosisinengland
‡A
Views of Young People in Early Intervention Services for First-Episode Psychosis in England
‡9
1
|
919
|
|
|
‡a
visuospatiallearningandexecutivefunctionareindependentlyimpairedin1episodepsychosis
‡A
Visuospatial learning and executive function are independently impaired in first-episode psychosis.
‡9
1
|
919
|
|
|
‡a
vitamin500supplementationduringthe1yearoflifeandriskofschizophreniaafinnishbirthcohortstudy
‡A
Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study
‡9
1
|
919
|
|
|
‡a
volumesofbraingreyandwhitematterandcerebrospinalfluidinschizophreniainthenorthernfinland1966birthcohortanepidemiologicalapproachtoanalysis
‡A
Volumes of brain, grey and white matter and cerebrospinal fluid in schizophrenia in the Northern Finland 1966 Birth Cohort: an epidemiological approach to analysis
‡9
1
|
919
|
|
|
‡a
warexperiencesgeneralfunctioningandbarrierstocareamongformerchildsoldiersinnorthernugandathewaysstudy
‡A
War experiences, general functioning and barriers to care among former child soldiers in Northern Uganda: the WAYS study
‡9
1
|
919
|
|
|
‡a
whichcharacteristicsofschizophreniapredatepsychosis
‡A
Which characteristics of schizophrenia predate psychosis?
‡9
1
|
919
|
|
|
‡a
whitematterstructureinyoungadultswithfamilialriskforpsychosistheoulubrainandmindstudy
‡A
White matter structure in young adults with familial risk for psychosis - The Oulu Brain and Mind Study
‡9
1
|
919
|
|
|
‡a
whypsychiatrycantaffordtobeneurophobic
‡A
Why psychiatry can't afford to be neurophobic
‡9
1
|
919
|
|
|
‡a
youngpeopleatriskforpsychosiscasefindingandsamplecharacteristicsoftheoulubrainandmindstudy
‡A
Young people at risk for psychosis: case finding and sample characteristics of the Oulu Brain and Mind Study
‡9
1
|
919
|
|
|
‡a
youngpeoplesviewsofukmentalhealthservices
‡A
Young people's views of UK mental health services
‡9
1
|
919
|
|
|
‡a
5httlprandearlychildhoodadversitiesmoderatecognitiveandemotionalprocessinginadolescence
‡A
5-HTTLPR and early childhood adversities moderate cognitive and emotional processing in adolescence
‡9
1
|
919
|
|
|
‡a
classcontrastivehumaninterpretablemachinelearningapproachtopredictmortalityinseverementalillness
‡A
A class-contrastive human-interpretable machine learning approach to predict mortality in severe mental illness
‡9
1
|
919
|
|
|
‡a
comparisonofclinicalandresearchdsm3rdiagnosesofschizophreniainafinnishnationalbirthcohortclinicalandresearchdiagnosesofschizophrenia
‡A
A comparison of clinical and research DSM-III-R diagnoses of schizophrenia in a Finnish national birth cohort. Clinical and research diagnoses of schizophrenia
‡9
1
|
919
|
|
|
‡a
computationalanalysisofabnormalbeliefupdatingprocessesandtheirassociationwithpsychoticexperiencesandchildhoodtraumainaukbirthcohort
‡A
A Computational Analysis of Abnormal Belief Updating Processes and Their Association With Psychotic Experiences and Childhood Trauma in a UK Birth Cohort
‡9
1
|
919
|
|
|
‡a
longitudinaltypologyofsymptomsofdepressionandanxietyoverthelifecourse
‡A
A longitudinal typology of symptoms of depression and anxiety over the life course
‡9
1
|
919
|
|
|
‡a
populationbasedlongitudinalstudyofchildhoodneurodevelopmentaldisordersiqandsubsequentriskofpsychoticexperiencesinadolescence
‡A
A population-based longitudinal study of childhood neurodevelopmental disorders, IQ and subsequent risk of psychotic experiences in adolescence
‡9
1
|
919
|
|
|
‡a
populationbasedprospectivebirthcohortstudyofchildhoodneurocognitiveandpsychologicalfunctioninginhealthysurvivorsofearlylifemeningitis
‡A
A population-based prospective birth cohort study of childhood neurocognitive and psychological functioning in healthy survivors of early life meningitis
‡9
1
|
919
|
|
|
‡a
populationbasedstudyofatopicdisordersandinflammatorymarkersinchildhoodbeforepsychoticexperiencesinadolescence
‡A
A population-based study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence
‡9
1
|
919
|
|
|
‡a
populationbasedstudyofgeneticvariationandpsychoticexperiencesinadolescents
‡A
A population-based study of genetic variation and psychotic experiences in adolescents
‡9
1
|
919
|
|
|
‡a
populationlevelpredictiontoolfortheincidenceof1episodepsychosistranslationalepidemiologybasedoncrosssectionaldata
‡A
A population-level prediction tool for the incidence of first-episode psychosis: translational epidemiology based on cross-sectional data
‡9
1
|
919
|
|
|
‡a
quantitativemetaanalysisofpopulationbasedstudiesofpremorbidintelligenceandschizophrenia
‡A
A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia.
‡9
1
|
919
|
|
|
‡a
randomizedcontrolledtrialofthecostutilityof2generationantipsychoticsinpeoplewithpsychosisandeligibleforclozapine
‡A
A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapine
‡9
1
|
919
|
|
|
‡a
abnormalrewardpredictionerrorsignallinginantipsychoticnaiveindividualswith1episodepsychosisorclinicalriskforpsychosis
‡A
Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis.
‡9
1
|
919
|
|
|
‡a
acuteandtransientpsychoticdisordersprecursorsepidemiologycourseandoutcome
‡A
Acute and transient psychotic disorders: precursors, epidemiology, course and outcome.
‡9
1
|
919
|
|
|
‡a
administrativeincidenceofpsychosisassessedinanearlyinterventionserviceinengland1epidemiologicalevidencefromadiverseruralandurbansetting
‡A
Administrative incidence of psychosis assessed in an early intervention service in England: first epidemiological evidence from a diverse, rural and urban setting.
‡9
1
|
919
|
|
|
‡a
adolescenceisassociatedwithgenomicallypatternedconsolidationofthehubsofthehumanbrainconnectome
‡A
Adolescence is associated with genomically patterned consolidation of the hubs of the human brain connectome
‡9
1
|
919
|
|
|
‡a
adolescentfriendshipspredictlaterresilientfunctioningacrosspsychosocialdomainsinahealthycommunitycohort
‡A
Adolescent friendships predict later resilient functioning across psychosocial domains in a healthy community cohort
‡9
1
|
919
|
|
|
‡a
adolescentselfcontrolpredictsmidlifehallucinatoryexperiences40yearfollowupofanationalbirthcohort
‡A
Adolescent self-control predicts midlife hallucinatory experiences: 40-year follow-up of a national birth cohort
‡9
1
|
919
|
|
|
‡a
adolescentselforganizationpredictsmidlifememoryinaprospectivebirthcohortstudy
‡A
Adolescent self-organization predicts midlife memory in a prospective birth cohort study
‡9
1
|
919
|
|
|
‡a
aggressivebehaviourat1contactwithservicesfindingsfromtheaesop1episodepsychosisstudy
‡A
Aggressive behaviour at first contact with services: findings from the AESOP First Episode Psychosis Study.
‡9
1
|
919
|
|
|
‡a
aggressiveincidentsin1episodepsychosis
‡A
Aggressive incidents in first-episode psychosis.
‡9
1
|
919
|
|
|
‡a
antipsychotictreatmentresistancein1episodepsychosisprevalencesubtypesandpredictors
‡A
Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors.
‡9
1
|
919
|
|
|
‡a
antipsychotictypeandcorrelatesofantipsychotictreatmentdiscontinuationintheoutpatienttreatmentofschizophrenia
‡A
Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophrenia
‡9
1
|
919
|
|
|
‡a
appraisalsofstressorsandcommonmentaldisorderfromearlytomidadulthoodinthe1946britishbirthcohort
‡A
Appraisals of stressors and common mental disorder from early to mid-adulthood in the 1946 British birth cohort
‡9
1
|
919
|
|
|
‡a
assessmentofposttraumaticsymptomsinpatientswith1episodepsychosis
‡A
Assessment of posttraumatic symptoms in patients with first-episode psychosis
‡9
1
|
919
|
|
|
‡a
assessmentofremissioninschizophreniawiththecgiandcgischscales
‡A
Assessment of remission in schizophrenia with the CGI and CGI-SCH scales
‡9
1
|
919
|
|
|
‡a
associationbetweencentralnervoussysteminfectionsduringchildhoodandadultonsetschizophreniaandotherpsychosesa28yearfollowup
‡A
Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up
‡9
1
|
919
|
|
|
‡a
associationbetweencommonearlychildhoodinfectionandsubsequentdepressivesymptomsandpsychoticexperiencesinadolescenceapopulationbasedlongitudinalbirthcohortstudy
‡A
Association between common early-childhood infection and subsequent depressive symptoms and psychotic experiences in adolescence: a population-based longitudinal birth cohort study
‡9
1
|
919
|
|
|
‡a
associationbetweendevelopmentalmilestonesandageofschizophreniaonsetresultsfromthenorthernfinlandbirthcohort
‡A
Association between developmental milestones and age of schizophrenia onset: Results from the Northern Finland Birth Cohort 1966
‡9
1
|
919
|
|
|
‡a
associationbetweendurationofuntreatedpsychosisandbrainmorphologyinschizophreniawithinthenorthernfinland1966birthcohort
‡A
Association between duration of untreated psychosis and brain morphology in schizophrenia within the Northern Finland 1966 Birth Cohort.
‡9
1
|
919
|
|
|
‡a
associationbetweendurationofuntreatedpsychosisandoutcomeincohortsof1episodepatientsasystematicreview
‡A
Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review
‡9
1
|
919
|
|
|
‡a
associationbetweenserum100reactiveproteinanddsm4generalizedanxietydisorderinadolescencefindingsfromthealspaccohort
‡A
Association between serum C-reactive protein and DSM-IV generalized anxiety disorder in adolescence: Findings from the ALSPAC cohort.
‡9
1
|
919
|
|
|
‡a
associationofcannabisusewithprodromalsymptomsofpsychosisinadolescence
‡A
Association of cannabis use with prodromal symptoms of psychosis in adolescence
‡9
1
|
919
|
|
|
‡a
associationofextentofcannabisuseandpsychoticlikeintoxicationexperiencesinamultinationalsampleof1episodepsychosispatientsandcontrols
‡A
Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls
‡9
1
|
919
|
|
|
‡a
associationofseruminterleukin6and100reactiveproteininchildhoodwithdepressionandpsychosisinyoungadultlifeapopulationbasedlongitudinalstudy
‡A
Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study
‡9
1
|
919
|
|
|
‡a
associationsbetweenearlydevelopmentandoutcomeinschizophreniaa35yearfollowupofthenorthernfinland1966birthcohort
‡A
Associations between early development and outcome in schizophrenia — A 35-year follow-up of the Northern Finland 1966 Birth Cohort
‡9
1
|
919
|
|
|
‡a
authorsreplyrelongitudinaleffectofclozapineassociatedsedationonmotivationinschizophrenianaturalisticlongitudinalstudy
‡A
Author's Reply. RE: Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study
‡9
1
|
919
|
|
|
‡a
autoimmunediseasesinthepedigreesofschizophrenicandcontrolsubjects
‡A
Autoimmune diseases in the pedigrees of schizophrenic and control subjects
‡9
1
|
919
|
|
|
‡a
bilateralhippocampalincreasefollowing1episodepsychosisisassociatedwithgoodclinicalfunctionalandcognitiveoutcomes
‡A
Bilateral hippocampal increase following first-episode psychosis is associated with good clinical, functional and cognitive outcomes
‡9
1
|
919
|
|
|
‡a
biologicalandpsychosocialriskfactorsforpsychoticmajordepression
‡A
Biological and psychosocial risk factors for psychotic major depression.
‡9
1
|
919
|
|
|
‡a
birthcohortstudiesinpsychiatrybeginningatthebeginning
‡A
Birth cohort studies in psychiatry: beginning at the beginning
‡9
1
|
919
|
|
|
‡a
birthorderandriskforschizophreniaa31yearfollowupofthenorthernfinland1966birthcohort
‡A
Birth order and risk for schizophrenia: a 31-year follow-up of the Northern Finland 1966 Birth Cohort
‡9
1
|
919
|
|
|
‡a
brainbehaviourmodesofcovariationinhealthyandclinicallydepressedyoungpeople
‡A
Brain-behaviour modes of covariation in healthy and clinically depressed young people
‡9
1
|
919
|
|
|
‡a
brainmicroarchitectureanddisinhibitionalatentphenotypingstudyacross33impulsiveandcompulsivebehaviours
‡A
Brain micro-architecture and disinhibition: a latent phenotyping study across 33 impulsive and compulsive behaviours
‡9
1
|
919
|
|
|
‡a
brainstructureindifferentpsychosisriskgroupsinthenorthernfinland1986birthcohort
‡A
Brain structure in different psychosis risk groups in the Northern Finland 1986 Birth Cohort
‡9
1
|
919
|
|
|
‡a
breakingtheweblifebeyondtheatriskmentalstateforpsychosis
‡A
Breaking the web: life beyond the at-risk mental state for psychosis
‡9
1
|
919
|
|
|
‡a
cannabisandacutepsychosis
‡A
Cannabis and acute psychosis.
‡9
1
|
919
|
|
|
‡a
cannabisandschizophreniamodelprojectionsoftheimpactoftheriseincannabisuseonhistoricalandfuturetrendsinschizophreniainenglandandwales
‡A
Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales
‡9
1
|
919
|
|
|
‡a
cannabisuseandoutcomeofrecentonsetpsychosis
‡A
Cannabis use and outcome of recent onset psychosis
‡9
1
|
919
|
|
|
‡a
cannabisuseandriskofpsychoticoraffectivementalhealthoutcomesasystematicreview
‡A
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
‡9
1
|
919
|
|
|
‡a
cannabisusegenderandageofonsetofschizophreniadatafromtheaesopstudy
‡A
Cannabis use, gender and age of onset of schizophrenia: data from the ÆSOP study
‡9
1
|
919
|
|
|
‡a
cannabisuseisassociatedwithincreasedccl11plasmalevelsinyounghealthyvolunteers
‡A
Cannabis use is associated with increased CCL11 plasma levels in young healthy volunteers
‡9
1
|
919
|
|
|
‡a
caregivingin1episodepsychosissocialcharacteristicsassociatedwithperceivedburdenandassociationswithcompulsorytreatment
‡A
Caregiving in first-episode psychosis: social characteristics associated with perceived ‘burden’ and associations with compulsory treatment
‡9
1
|
919
|
|
|
‡a
changesinverballearningandmemoryinschizophreniaandnonpsychoticcontrolsinmidlifea9yearfollowupinthenorthernfinlandbirthcohortstudy
‡A
Changes in verbal learning and memory in schizophrenia and non-psychotic controls in midlife: A nine-year follow-up in the Northern Finland Birth Cohort study 1966.
‡9
1
|
919
|
|
|
‡a
childdevelopmentriskfactorsforadultschizophreniainthebritish1946birthcohort
‡A
Child development risk factors for adult schizophrenia in the British 1946 birth cohort
‡9
1
|
919
|
|
|
‡a
childhoodadversitysubtypesanddepressivesymptomsinearlyandlateadolescence
‡A
Childhood adversity subtypes and depressive symptoms in early and late adolescence
‡9
1
|
919
|
|
|
‡a
childhoodcentralnervoussysteminfectionsandriskforschizophrenia
‡A
Childhood central nervous system infections and risk for schizophrenia
‡9
1
|
919
|
|
|
‡a
childhoodcognitiveabilityandadultmentalhealthinthebritish1946birthcohort
‡A
Childhood cognitive ability and adult mental health in the British 1946 birth cohort
‡9
1
|
919
|
|
|
‡a
childhoodcognitivefunctionandadultpsychopathologyassociationswithpsychoticandnonpsychoticsymptomsinthegeneralpopulation
‡A
Childhood cognitive function and adult psychopathology: associations with psychotic and non-psychotic symptoms in the general population
‡9
1
|
919
|
|
|
‡a
childhoodepsteinbarrvirusinfectionandsubsequentriskofpsychoticexperiencesinadolescenceapopulationbasedprospectiveserologicalstudy
‡A
Childhood Epstein-Barr Virus infection and subsequent risk of psychotic experiences in adolescence: a population-based prospective serological study
‡9
1
|
919
|
|
|
‡a
childhoodinfectionandadultschizophreniaametaanalysisofpopulationbasedstudies
‡A
Childhood infection and adult schizophrenia: a meta-analysis of population-based studies
‡9
1
|
919
|
|
|
‡a
childhoodlateralityandlaterriskofschizophreniainthe1946britishbirthcohort
‡A
Childhood laterality and later risk of schizophrenia in the 1946 British birth cohort
‡9
1
|
919
|
|
|
‡a
childhoodschizotypyandpositivesymptomsinschizophrenicpatientspredictschizotypyinrelatives
‡A
Childhood schizotypy and positive symptoms in schizophrenic patients predict schizotypy in relatives
‡9
1
|
919
|
|
|
‡a
childhoodtraumaandcognitivefunctionin1episodeaffectiveandnonaffectivepsychosis
‡A
Childhood trauma and cognitive function in first-episode affective and non-affective psychosis
‡9
1
|
919
|
|
|
‡a
clinicalandsocialdeterminantsofdurationofuntreatedpsychosisintheaesop1episodepsychosisstudy
‡A
Clinical and social determinants of duration of untreated psychosis in the AESOP first-episode psychosis study.
‡9
1
|
919
|
|
|
‡a
clinicalandsociodemographiccomparisonofpeopleathighriskforpsychosisandwith1episodepsychosis
‡A
Clinical and sociodemographic comparison of people at high-risk for psychosis and with first-episode psychosis
‡9
1
|
919
|
|
|
‡a
cognitivebehaviourtherapyforimprovingsocialrecoveryinpsychosiscosteffectivenessanalysis
‡A
Cognitive behaviour therapy for improving social recovery in psychosis: Cost-effectiveness analysis
‡9
1
|
919
|
|
|
‡a
cognitiveeffectsofgeneticvariationinmonoamineneurotransmittersystemsapopulationbasedstudyofcomtmaoaand5httlpr
‡A
Cognitive effects of genetic variation in monoamine neurotransmitter systems: a population-based study of COMT, MAOA, and 5HTTLPR.
‡9
1
|
919
|
|
|
‡a
cognitivereserveinneuropsychiatry
‡A
Cognitive reserve in neuropsychiatry.
‡9
1
|
919
|
|
|
‡a
cohortprofilementalhealthfollowingextremetraumainanorthernugandancohortofwaraffectedyouthstudy
‡A
Cohort profile: mental health following extreme trauma in a northern Ugandan cohort of War-Affected Youth Study
‡9
1
|
919
|
|
|
‡a
cohortprofilementalhealthfollowingextremetraumainanorthernugandancohortofwaraffectedyouthstudythewaysstudy
‡A
Cohort profile: mental health following extreme trauma in a northern Ugandan cohort of War-Affected Youth Study (The WAYS Study).
‡9
1
|
919
|
|
|
‡a
cohortprofileriskpatternsandprocessesforpsychopathologyemergingduringadolescencetherootsproject
‡A
Cohort profile: risk patterns and processes for psychopathology emerging during adolescence: the ROOTS project
‡9
1
|
919
|
|
|
‡a
combiningdimensionalandcategoricalrepresentationofpsychosisthewayforwardfordsm5andicd11
‡A
Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11?
‡9
1
|
919
|
|
|
‡a
commonversuspsychopathologyspecificriskfactorsforpsychoticexperiencesanddepressionduringadolescence
‡A
Common versus psychopathology-specific risk factors for psychotic experiences and depression during adolescence
‡9
1
|
919
|
|
|
‡a
comparativeeffectivenessofcognitivetherapiesdeliveredfacetofaceoroverthetelephoneanobservationalstudyusingpropensitymethods
‡A
Comparative effectiveness of cognitive therapies delivered face-to-face or over the telephone: an observational study using propensity methods
‡9
1
|
919
|
|
|
‡a
comparingtimeuseinindividualsatdifferentstagesofpsychosisandanonclinicalcomparisongroup
‡A
Comparing time use in individuals at different stages of psychosis and a non-clinical comparison group
‡9
1
|
919
|
|
|
‡a
comparisonofhighandlowintensitycontactbetweensecondaryandprimarycaretodetectpeopleatultrahighriskforpsychosisstudyprotocolforatheorybasedclusterrandomizedcontrolledtrial
‡A
Comparison of high and low intensity contact between secondary and primary care to detect people at ultra-high risk for psychosis: study protocol for a theory-based, cluster randomized controlled trial
‡9
1
|
919
|
|
|
‡a
compulsivityandimpulsivitytraitslinkedtoattenuateddevelopmentalfrontostriatalmyelinationtrajectories
‡A
Compulsivity and impulsivity traits linked to attenuated developmental frontostriatal myelination trajectories
‡9
1
|
919
|
|
|
‡a
correctionsharedmechanismsbetweencoronaryheartdiseaseanddepressionfindingsfromalargeukgeneralpopulationbasedcohort
‡A
Correction: Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort
‡9
1
|
919
|
|
|
‡a
costeffectivenessof152generationantipsychoticdrugsresultsfromarandomisedcontrolledtrialinschizophreniarespondingpoorlytoprevioustherapy
‡A
Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy.
‡9
1
|
919
|
|
|
‡a
costofimprovingaccesstopsychologicaltherapiesiaptprogrammeananalysisofcostofsessiontreatmentandrecoveryinselectedprimarycaretrustsintheeastofenglandregion
‡A
Cost of improving Access to Psychological Therapies (IAPT) programme: an analysis of cost of session, treatment and recovery in selected Primary Care Trusts in the East of England region
‡9
1
|
919
|
|
|
‡a
criminaloffendinganddistinguishingfeaturesofoffendersamongpersonsexperiencinga1episodeofpsychosis
‡A
Criminal offending and distinguishing features of offenders among persons experiencing a first episode of psychosis
‡9
1
|
919
|
|
|
‡a
crossnationalclinicalandfunctionalremissionratesworldwideschizophreniaoutpatienthealthoutcomes
‡A
Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes
‡9
1
|
919
|
|
|
‡a
crossnationalclinicalandfunctionalremissionratesworldwideschizophreniaoutpatienthealthoutcomeswsohostudy
‡A
Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study
‡9
1
|
919
|
|
|
‡a
culturaldifferencesinpathwaystocareserviceuseandtreatedoutcomes
‡A
Cultural differences in pathways to care, service use and treated outcomes
‡9
1
|
919
|
|
|
‡a
cumulativesocialdisadvantageethnicityand1episodepsychosisacasecontrolstudy
‡A
Cumulative social disadvantage, ethnicity and first-episode psychosis: a case-control study
‡9
1
|
919
|
|
|
‡a
dailyuseofhighpotencycannabisisassociatedwithmorepositivesymptomsin1episodepsychosispatientstheeugeicasecontrolstudy
‡A
Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study
‡9
1
|
919
|
|
|
‡a
defaultmodenetworkinyoungpeoplewithfamilialriskforpsychosistheoulubrainandmindstudy
‡A
Default mode network in young people with familial risk for psychosis--the Oulu Brain and Mind study
‡9
1
|
919
|
|
|
‡a
definingtheneedsofpatientswithintellectualdisabilitiesinthehighsecuritypsychiatrichospitalsinengland
‡A
Defining the needs of patients with intellectual disabilities in the high security psychiatric hospitals in England.
‡9
1
|
919
|
|
|
‡a
depressivesymptomsduringadolescencecomparisonbetweenepidemiologicalandhighrisksampling
‡A
Depressive symptoms during adolescence: comparison between epidemiological and high risk sampling
‡9
1
|
919
|
|
|
‡a
determiningthechronologyandcomponentsofpsychosisonsetthenottinghamonsetschedule
‡A
Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule
‡9
1
|
919
|
|
|
‡a
determiningthechronologyandcomponentsofpsychosisonsetthenottinghamonsetschedulenos
‡A
Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule (NOS).
‡9
1
|
919
|
|
|
‡a
developmentalcognitiveneuroscienceusinglatentchangescoremodelsatutorialandapplications
‡A
Developmental cognitive neuroscience using latent change score models: A tutorial and applications.
‡9
1
|
919
|
|
|
‡a
developmentaltypologyoftrajectoriestonighttimebladdercontrolepidemiologicapplicationoflongitudinallatentclassanalysis
‡A
Developmental typology of trajectories to nighttime bladder control: epidemiologic application of longitudinal latent class analysis
‡9
1
|
919
|
|
|
‡a
deviantintrauterinegrowthandriskofschizophreniaa34yearfollowupofthenorthernfinland1966birthcohort
‡A
Deviant intrauterine growth and risk of schizophrenia: a 34-year follow-up of the Northern Finland 1966 Birth Cohort
‡9
1
|
919
|
|
|
‡a
diagnosticchange10yearsaftera1episodeofpsychosis
‡A
Diagnostic change 10 years after a first episode of psychosis
‡9
1
|
919
|
|
|
‡a
diagnosticstabilityandoutcomeafter1episodepsychosis
‡A
Diagnostic stability and outcome after first episode psychosis
‡9
1
|
919
|
|
|
‡a
differenteffectsoftypicalandatypicalantipsychoticsongreymatterin1episodepsychosistheaesopstudy
‡A
Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study
‡9
1
|
919
|
|
|
‡a
differentvulnerabilityindicatorsforpsychosisandtheirneuropsychologicalcharacteristicsinthenorthernfinland1986birthcohort
‡A
Different vulnerability indicators for psychosis and their neuropsychological characteristics in the Northern Finland 1986 Birth Cohort
‡9
1
|
919
|
|
|
‡a
differentialrelationshipbetweenneurologicalandcognitivedysfunctionin1episodepsychosispatientsandinhealthyindividuals
‡A
Differential relationship between neurological and cognitive dysfunction in first episode psychosis patients and in healthy individuals
‡9
1
|
919
|
|
|
‡a
differingpatternsofbrainstructuralabnormalitiesbetweenblackandwhitepatientswiththeir1episodeofpsychosis
‡A
Differing patterns of brain structural abnormalities between black and white patients with their first episode of psychosis
‡9
1
|
919
|
|
|
‡a
dischargedfromspecialhospitalunderrestrictionsacomparisonofthefatesofpsychopathsandthementallyill
‡A
Discharged from special hospital under restrictions: a comparison of the fates of psychopaths and the mentally ill
‡9
1
|
919
|
|
|
‡a
diseaserelevantautoantibodiesin1episodeschizophrenia
‡A
Disease-relevant autoantibodies in first episode schizophrenia
‡9
1
|
919
|
|
|
‡a
doobstetriccomplicationscausetheearlierageatonsetinmalethanfemaleschizophrenics
‡A
Do obstetric complications cause the earlier age at onset in male than female schizophrenics?
‡9
1
|
919
|
|
|
‡a
doesmaternalbodymassindexduringpregnancyinfluenceriskofschizophreniaintheadultoffspring
‡A
Does maternal body mass index during pregnancy influence risk of schizophrenia in the adult offspring?
‡9
1
|
919
|
|
|
‡a
durationofprodromalphaseandseverityofvolumetricabnormalitiesin1episodepsychosis
‡A
Duration of prodromal phase and severity of volumetric abnormalities in first-episode psychosis
‡9
1
|
919
|
|
|
‡a
durationofuntreatedpsychosisandethnicityintheaesop1onsetpsychosisstudy
‡A
Duration of untreated psychosis and ethnicity in the AESOP first-onset psychosis study
‡9
1
|
919
|
|
|
‡a
durationofuntreatedpsychosisandneuropsychologicalfunctionin1episodepsychosis
‡A
Duration of untreated psychosis and neuropsychological function in first episode psychosis.
‡9
1
|
919
|
|
|
‡a
earlydetectionandinterventionevaluationforpeopleathighriskofpsychosis2edie2trialrationaledesignandbaselinecharacteristics
‡A
Early detection and intervention evaluation for people at high-risk of psychosis-2 (EDIE-2): trial rationale, design and baseline characteristics.
‡9
1
|
919
|
|
|
‡a
earlydetectionandinterventionevaluationforpeopleatriskofpsychosismultisiterandomisedcontrolledtrial
‡A
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial.
‡9
1
|
919
|
|
|
‡a
earlydevelopmentstressanddepressionacrossthelifecoursepathwaystodepressioninanationalbritishbirthcohort
‡A
Early development, stress and depression across the life course: pathways to depression in a national British birth cohort
‡9
1
|
919
|
|
|
‡a
earlyinterventionforincipientinsanityearlynotionsfromthe19thcenturyenglishliterature
‡A
Early intervention for incipient insanity: early notions from the 19(th) century English literature.
‡9
1
|
919
|
|
|
‡a
earlyinterventioninpsychosiskeepingthebodyinmind
‡A
Early intervention in psychosis: keeping the body in mind
‡9
1
|
919
|
|
|
‡a
earlyinterventionservicesinpsychosisfromevidencetowideimplementation
‡A
Early intervention services in psychosis: from evidence to wide implementation.
‡9
1
|
919
|
|
|
‡a
earlyriskfactorsandadultpersonenvironmentrelationshipsinaffectivedisorder
‡A
Early risk factors and adult person--environment relationships in affective disorder.
‡9
1
|
919
|
|
|
‡a
earlyriskfactorsforsuicideinanepidemiological1episodepsychosiscohort
‡A
Early risk factors for suicide in an epidemiological first episode psychosis cohort
‡9
1
|
919
|
|
|
‡a
earlysustainedrecoveryfollowing1episodepsychosisevidencefromtheaesop10followupstudy
‡A
Early sustained recovery following first episode psychosis: Evidence from the AESOP10 follow-up study.
‡9
1
|
919
|
|
|
‡a
educationalconsequencesofmentaldisorderstreatedinhospitala31yearfollowupofthenorthernfinland1966birthcohort
‡A
Educational consequences of mental disorders treated in hospital. A 31-year follow-up of the Northern Finland 1966 Birth Cohort.
‡9
1
|
919
|
|
|
‡a
effectofdelayingtreatmentof1episodepsychosisonsymptomsandsocialoutcomesalongitudinalanalysisandmodellingstudy
‡A
Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes: a longitudinal analysis and modelling study
‡9
1
|
919
|
|
|
‡a
effectofpriortreatmentwithantipsychoticlongactinginjectiononrandomisedclinicaltrialtreatmentoutcomes
‡A
Effect of prior treatment with antipsychotic long-acting injection on randomised clinical trial treatment outcomes
‡9
1
|
919
|
|
|
‡a
effectivenessofantipsychotictreatmentforschizophrenia6monthresultsofthepaneuropeanschizophreniaoutpatienthealthoutcomes
‡A
Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes
‡9
1
|
919
|
|
|
‡a
effectivenessofantipsychotictreatmentforschizophrenia6monthresultsofthepaneuropeanschizophreniaoutpatienthealthoutcomessohostudy
‡A
Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study
‡9
1
|
919
|
|
|
‡a
effectsofcannabisuseonoutcomesofpsychoticdisorderssystematicreview
‡A
Effects of cannabis use on outcomes of psychotic disorders: systematic review
‡9
1
|
919
|
|
|
‡a
effectsofcatecholomethyltransferaseonnormalvariationinthecognitivefunctionofchildren
‡A
Effects of catechol-O-methyltransferase on normal variation in the cognitive function of children
‡9
1
|
919
|
|
|
‡a
effectsofmodafiniloncognitivefunctionsin1episodepsychosis
‡A
Effects of modafinil on cognitive functions in first episode psychosis
‡9
1
|
919
|
|
|
‡a
effectsofmodafinilonemotionalprocessingin1episodepsychosis
‡A
Effects of modafinil on emotional processing in first episode psychosis
‡9
1
|
919
|
|
|
‡a
effectsofthecatecholomethyltransferaseval158metpolymorphismonexecutivefunctionametaanalysisofthewisconsincardsorttestinschizophreniaandhealthycontrols
‡A
Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls
‡9
1
|
919
|
|
|
‡a
elevatedmorningcortisolisastratifiedpopulationlevelbiomarkerformajordepressioninboysonlywithhighdepressivesymptoms
‡A
Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms
‡9
1
|
919
|
|
|
‡a
epidemiologicalaspectsofmigrationandmentalillness
‡A
Epidemiological aspects of migration and mental illness
‡9
1
|
919
|
|
|
‡a
epidemiologicalchallengesinsystematicreviews
‡A
Epidemiological challenges in systematic reviews
‡9
1
|
919
|
|
|
‡a
establishingatheorybasedmultilevelapproachforprimarypreventionofmentaldisordersinyoungpeople
‡A
Establishing a Theory-Based Multi-Level Approach for Primary Prevention of Mental Disorders in Young People
‡9
1
|
919
|
|
|
‡a
ethnicidentityperceptionsofdisadvantageandpsychosisfindingsfromtheaesopstudy
‡A
Ethnic identity, perceptions of disadvantage, and psychosis: findings from the ÆSOP study
‡9
1
|
919
|
|
|
‡a
ethnicityandmentalhealththeexampleofschizophreniaandrelatedpsychosesinmigrantpopulationsinthewesternworld
‡A
Ethnicity and mental health: the example of schizophrenia and related psychoses in migrant populations in the Western world
‡9
1
|
919
|
|
|
‡a
ethnicityandmentalhealththeexampleofschizophreniainmigrantpopulationsacrosseurope
‡A
Ethnicity and mental health: the example of schizophrenia in migrant populations across Europe
‡9
1
|
919
|
|
|
‡a
ethnicityandmentalhealththeexampleofschizophreniaintheafricancaribbeanpopulationineurope
‡A
Ethnicity and Mental Health: The Example of Schizophrenia in the African-Caribbean Population in Europe
‡9
1
|
919
|
|
|
‡a
ethnicitysocialdisadvantageandpsychoticlikeexperiencesinahealthypopulationbasedsample
‡A
Ethnicity, social disadvantage and psychotic-like experiences in a healthy population based sample
‡9
1
|
919
|
|
|
‡a
examiningevidenceforneighbourhoodvariationinthedurationofuntreatedpsychosis
‡A
Examining evidence for neighbourhood variation in the duration of untreated psychosis.
‡9
1
|
919
|
|
|
‡a
examiningpathwaysbetweengeneticliabilityforschizophreniaandpatternsoftobaccoandcannabisuseinadolescence
‡A
Examining pathways between genetic liability for schizophrenia and patterns of tobacco and cannabis use in adolescence
‡9
1
|
919
|
|
|
‡a
exerciseanddepressivesymptomsinadolescentsalongitudinalcohortstudy
‡A
Exercise and depressive symptoms in adolescents: a longitudinal cohort study
‡9
1
|
919
|
|
|
‡a
explainingsexdifferencesincourseandoutcomeinthefunctionalpsychoses
‡A
Explaining sex differences in course and outcome in the functional psychoses
‡9
1
|
919
|
|
|
‡a
expressedemotionrelevancetorehospitalizationinschizophreniaover7years
‡A
Expressed emotion: relevance to rehospitalization in schizophrenia over 7 years
‡9
1
|
919
|
|
|
‡a
extrapyramidalmotorsideeffectsof1and2generationantipsychoticdrugs
‡A
Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs
‡9
1
|
919
|
|
|
‡a
factorsassociatedwithantidepressantanxiolyticandhypnoticuseover17yearsinanationalcohort
‡A
Factors associated with antidepressant, anxiolytic and hypnotic use over 17 years in a national cohort
‡9
1
|
919
|
|
|
‡a
familyhistoryofautoimmunediseasesinpsychosis
‡A
Family history of autoimmune diseases in psychosis
‡9
1
|
919
|
|
|
‡a
1vs2generationantipsychoticdrugsinschizophreniareply
‡A
First- vs Second-Generation Antipsychotic Drugs in Schizophrenia—Reply
‡9
1
|
919
|
|
|
‡a
fortyyearpsychiatricoutcomesfollowingassessmentforinternalizingdisorderinadolescence
‡A
Forty-year psychiatric outcomes following assessment for internalizing disorder in adolescence.
‡9
1
|
919
|
|
|
‡a
friendshipsandfamilysupportreducesubsequentdepressivesymptomsinatriskadolescents
‡A
Friendships and Family Support Reduce Subsequent Depressive Symptoms in At-Risk Adolescents
‡9
1
|
919
|
|
|
‡a
frontocerebellarsystemsareassociatedwithinfantmotorandadultexecutivefunctionsinhealthyadultsbutnotinschizophrenia
‡A
Fronto-cerebellar systems are associated with infant motor and adult executive functions in healthy adults but not in schizophrenia
‡9
1
|
919
|
|
|
‡a
functionaldysconnectivityofcorticostriatalcircuitryasariskphenotypeforpsychosis
‡A
Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis
‡9
1
|
919
|
|
|
‡a
functionalmappingofdynamichappyandfearfulfacialexpressionsinyoungadultswithfamilialriskforpsychosisoulubrainandmindstudy
‡A
Functional mapping of dynamic happy and fearful facial expressions in young adults with familial risk for psychosis - Oulu Brain and Mind Study
‡9
1
|
919
|
|
|
‡a
genderdifferencesinincidenceandageatonsetofmaniaandbipolardisorderovera35yearperiodincamberwellengland
‡A
Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England.
‡9
1
|
919
|
|
|
‡a
genderdifferencesinneuropsychologicalperformanceacrosspsychoticdisordersamulticentrepopulationbasedcasecontrolstudy
‡A
Gender differences in neuropsychological performance across psychotic disorders--a multi-centre population based case-control study
‡9
1
|
919
|
|
|
‡a
genderdifferencesintheassociationbetweenchildhoodabuseandpsychosis
‡A
Gender differences in the association between childhood abuse and psychosis.
‡9
1
|
919
|
|
|
‡a
genderdifferencesintheassociationbetweenchildhoodphysicalandsexualabusesocialsupportandpsychosis
‡A
Gender differences in the association between childhood physical and sexual abuse, social support and psychosis
‡9
1
|
919
|
|
|
‡a
genderspecificeffectsofthecatecholomethyltransferaseval108158metpolymorphismoncognitivefunctioninchildren
‡A
Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children
‡9
1
|
919
|
|
|
‡a
geneexpressionanalysisinschizophreniareproducibleupregulationofseveralmembersoftheapolipoprotein50familylocatedinahighsusceptibilitylocusforschizophreniaonchromosome22
‡A
Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22.
‡9
1
|
919
|
|
|
‡a
generaldistresshopelessnesssuicidalideationandworryinginadolescenceconcurrentandpredictivevalidityofasymptomlevelbifactormodelforclinicaldiagnoses
‡A
General distress, hopelessness-suicidal ideation and worrying in adolescence: concurrent and predictive validity of a symptom-level bifactor model for clinical diagnoses.
‡9
1
|
919
|
|
|
‡a
genesandthesocialenvironment
‡A
Genes and the social environment
‡9
1
|
919
|
|
|
‡a
genesvirusesandneurodevelopmentalschizophrenia
‡A
Genes, viruses and neurodevelopmental schizophrenia
‡9
1
|
919
|
|
|
‡a
globalpopulationattributablefractionofpotentiallymodifiableriskfactorsformentaldisordersametaumbrellasystematicreview
‡A
Global population attributable fraction of potentially modifiable risk factors for mental disorders: a meta-umbrella systematic review
‡9
1
|
919
|
|
|
‡a
graymatterabnormalitiesassociatedwithdurationofuntreatedpsychosis
‡A
Gray matter abnormalities associated with duration of untreated psychosis
‡9
1
|
919
|
|
|
‡a
greymatterabnormalitiesin1episodeschizophreniaandaffectivepsychosis
‡A
Grey matter abnormalities in first-episode schizophrenia and affective psychosis
‡9
1
|
919
|
|
|
‡a
greymattercorrelatesofminorphysicalanomaliesintheaesop1episodepsychosisstudy
‡A
Grey matter correlates of minor physical anomalies in the AeSOP first-episode psychosis study
‡9
1
|
919
|
|
|
‡a
heterogeneityinincidenceratesofschizophreniaandotherpsychoticsyndromes
‡A
Heterogeneity in Incidence Rates of Schizophrenia and Other Psychotic Syndromes
‡9
1
|
919
|
|
|
‡a
hippocampusandamygdalavolumesinschizophreniaandotherpsychosesinthenorthernfinland1966birthcohort
‡A
Hippocampus and amygdala volumes in schizophrenia and other psychoses in the Northern Finland 1966 birth cohort
‡9
1
|
919
|
|
|
‡a
ifcannabiscausedschizophreniahowmanycannabisusersmayneedtobepreventedinordertoprevent1caseofschizophreniaenglandandwalescalculations
‡A
If cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations
‡9
1
|
919
|
|
|
‡a
illicitsubstanceuseanditscorrelatesin1episodepsychosis
‡A
Illicit substance use and its correlates in first episode psychosis
‡9
1
|
919
|
|
|
‡a
immunedysregulationamongstudentsexposedtoexamstressanditsmitigationbymindfulnesstrainingfindingsfromanexploratoryrandomisedtrial
‡A
Immune dysregulation among students exposed to exam stress and its mitigation by mindfulness training: findings from an exploratory randomised trial
‡9
1
|
919
|
|
|
‡a
immunotherapyforpatientswithacutepsychosisandserumnmethyl500aspartatereceptornmdarantibodiesadescriptionofatreatedcaseseries
‡A
Immunotherapy for patients with acute psychosis and serum N-Methyl D-Aspartate receptor (NMDAR) antibodies: a description of a treated case series
‡9
1
|
919
|
|
|
‡a
impactofcognitivetherapyoninternalisedstigmainpeoplewithatriskmentalstates
‡A
Impact of cognitive therapy on internalised stigma in people with at-risk mental states
‡9
1
|
919
|
|
|
‡a
impactofearlyinterventionservicesondurationofuntreatedpsychosisdatafromthenationaledenprospectivecohortstudy
‡A
Impact of early intervention services on duration of untreated psychosis: data from the National EDEN prospective cohort study
‡9
1
|
919
|
|
|
‡a
improvedqualityoflifeover1yearisassociatedwithimprovedadherenceinpatientswithschizophrenia
‡A
Improved quality of life over one year is associated with improved adherence in patients with schizophrenia.
‡9
1
|
919
|
|
|
‡a
improvementanddeclineofcognitivefunctioninschizophreniaover1yearalongitudinalinvestigationusinglatentgrowthmodelling
‡A
Improvement and decline of cognitive function in schizophrenia over one year: a longitudinal investigation using latent growth modelling
‡9
1
|
919
|
|
|
‡a
improvingaccesstopsychologicaltherapiesandolderpeoplefindingsfromtheeasternregion
‡A
Improving access to psychological therapies and older people: findings from the Eastern Region
‡9
1
|
919
|
|
|
‡a
incentivemotivationin1episodepsychosisabehaviouralstudy
‡A
Incentive motivation in first-episode psychosis: a behavioural study
‡9
1
|
919
|
|
|
‡a
incidenceanddistributionof1episodemaniabyageresultsfroma35yearstudy
‡A
Incidence and distribution of first-episode mania by age: results from a 35-year study.
‡9
1
|
919
|
|
|
‡a
incidenceofbipolaraffectivedisorderin3ukcitiesresultsfromtheaesopstudy
‡A
Incidence of bipolar affective disorder in three UK cities: results from the AESOP study.
‡9
1
|
919
|
|
|
‡a
incidenceofschizophreniaandotherpsychosesinengland19502009asystematicreviewandmetaanalyses
‡A
Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses
‡9
1
|
919
|
|
|
‡a
incidenceofschizophreniaandotherpsychosesinethnicminoritygroupsresultsfromthemrcaesopstudy
‡A
Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study
‡9
1
|
919
|
|
|
‡a
increasedincidenceofpsychoticdisordersinmigrantsfromthecaribbeantotheunitedkingdom
‡A
Increased incidence of psychotic disorders in migrants from the Caribbean to the United Kingdom.
‡9
1
|
919
|
|
|
‡a
increasedpituitaryvolumeinantipsychoticfreeandantipsychotictreatedpatientsoftheaesop1onsetpsychosisstudy
‡A
Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study
‡9
1
|
919
|
|
|
‡a
increasedriskofschizophreniafromadditiveinteractionbetweeninfantmotordevelopmentaldelayandobstetriccomplicationsevidencefromapopulationbasedlongitudinalstudy
‡A
Increased risk of schizophrenia from additive interaction between infant motor developmental delay and obstetric complications: evidence from a population-based longitudinal study
‡9
1
|
919
|
|
|
‡a
individualizedpredictionofillnesscourseatthe1psychoticepisodeasupportvectormachinemristudy
‡A
Individualized prediction of illness course at the first psychotic episode: a support vector machine MRI study
‡9
1
|
919
|
|
|
‡a
infantdevelopmentalmilestonesandsubsequentcognitivefunction
‡A
Infant developmental milestones and subsequent cognitive function
‡9
1
|
919
|
|
|
‡a
infantmotordevelopmentandadultcognitivefunctionsinschizophrenia
‡A
Infant motor development and adult cognitive functions in schizophrenia.
‡9
1
|
919
|
|
|
‡a
infantmotordevelopmentisassociatedwithadultcognitivecategorisationinalongitudinalbirthcohortstudy
‡A
Infant motor development is associated with adult cognitive categorisation in a longitudinal birth cohort study.
‡9
1
|
919
|
|
|
‡a
inflammationandimmunityinschizophreniaimplicationsforpathophysiologyandtreatment
‡A
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
‡9
1
|
919
|
|
|
‡a
insightgreymatterandcognitivefunctionin1onsetpsychosis
‡A
Insight, grey matter and cognitive function in first-onset psychosis
‡9
1
|
919
|
|
|
‡a
interactionbetweenparentalpsychosisandearlymotordevelopmentandtheriskofschizophreniainageneralpopulationbirthcohort
‡A
Interaction between parental psychosis and early motor development and the risk of schizophrenia in a general population birth cohort
‡9
1
|
919
|
|
|
‡a
interplaybetweenchildhoodphysicalabuseandfamilialriskintheonsetofpsychoticdisorders
‡A
Interplay between childhood physical abuse and familial risk in the onset of psychotic disorders
‡9
1
|
919
|
|
|
‡a
intrinsiccurvatureamarkerofmillimeterscaletangentialcorticocorticalconnectivity
‡A
Intrinsic curvature: a marker of millimeter-scale tangential cortico-cortical connectivity?
‡9
1
|
919
|
|
|
‡a
investigatingthegeneticarchitectureofgeneralandspecificpsychopathologyinadolescence
‡A
Investigating the genetic architecture of general and specific psychopathology in adolescence
‡9
1
|
919
|
|
|
‡a
iqinchildhoodpsychiatricattendeespredictsoutcomeoflaterschizophreniaat21yearfollowup
‡A
IQ in childhood psychiatric attendees predicts outcome of later schizophrenia at 21 year follow-up.
‡9
1
|
919
|
|
|
‡a
isprematurityassociatedwithadultcognitiveoutcomeandbrainstructure
‡A
Is prematurity associated with adult cognitive outcome and brain structure?
‡9
1
|
919
|
|
|
‡a
istheincidenceofpsychoticdisorderindeclineepidemiologicalevidencefrom2decadesofresearch
‡A
Is the incidence of psychotic disorder in decline? Epidemiological evidence from two decades of research
‡9
1
|
919
|
|
|
‡a
istherealinkbetweenchildhoodtraumacognitionandamygdalaandhippocampusvolumein1episodepsychosis
‡A
Is there a link between childhood trauma, cognition, and amygdala and hippocampus volume in first-episode psychosis?
‡9
1
|
919
|
|
|
‡a
jumpingtoconclusionsgeneralintelligenceandpsychosisliabilityfindingsfromthemulticentriceugeicasecontrolstudy
‡A
Jumping To Conclusions, General Intelligence, And Psychosis Liability: Findings From The Multicentric EU-GEI Case-Control Study
‡9
1
|
919
|
|
|
‡a
lifeeventsbeforepsychoticepisodesdoclinicalandsocialvariablesaffecttherelationship
‡A
Life events before psychotic episodes: do clinical and social variables affect the relationship?
‡9
1
|
919
|
|
|
‡a
lifemappingatherapeuticdocumentapproachtoneedsassessment
‡A
Life mapping: a 'Therapeutic Document' approach to needs assessment
‡9
1
|
919
|
|
|
‡a
lifetimeaffectandmidlifecognitivefunctionprospectivebirthcohortstudy
‡A
Lifetime affect and midlife cognitive function: prospective birth cohort study
‡9
1
|
919
|
|
|
‡a
lifetimeuseofantipsychoticmedicationanditsrelationtochangeofverballearningandmemoryinmidlifeschizophreniaanobservational9yearfollowupstudy
‡A
Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia - An observational 9-year follow-up study
‡9
1
|
919
|
|
|
‡a
lifetimeuseofpsychiatricmedicationsandcognitionat43yearsofageinschizophreniainthenorthernfinlandbirthcohort
‡A
Lifetime use of psychiatric medications and cognition at 43years of age in schizophrenia in the Northern Finland Birth Cohort 1966.
‡9
1
|
919
|
|
|
‡a
linearandnonlinearassociationsofsymptomdimensionsandcognitivefunctionin1onsetpsychosis
‡A
Linear and non-linear associations of symptom dimensions and cognitive function in first-onset psychosis
‡9
1
|
919
|
|
|
‡a
linkingthedevelopmentalanddegenerativetheoriesofschizophreniaassociationbetweeninfantdevelopmentandadultcognitivedecline
‡A
Linking the developmental and degenerative theories of schizophrenia: association between infant development and adult cognitive decline
‡9
1
|
919
|
|
|
‡a
linksbetweencreativityandmentaldisorder
‡A
Links between creativity and mental disorder
‡9
1
|
919
|
|
|
‡a
lithiuminbipolarandotheraffectivedisordersprescribingpracticeintheuk
‡A
Lithium in bipolar and other affective disorders: prescribing practice in the UK.
‡9
1
|
919
|
|
|
‡a
lithiumismoreeffectivethanplaceboforpreventingallrelapsesinpatientswithbipolarbutnotunipolardisorder
‡A
Lithium is more effective than placebo for preventing all relapses in patients with bipolar but not unipolar disorder
‡9
1
|
919
|
|
|
‡a
longitudinalassociationsbetweenchildhoodandadulthoodexternalizingandinternalizingpsychopathologyandadolescentsubstanceuse
‡A
Longitudinal associations between childhood and adulthood externalizing and internalizing psychopathology and adolescent substance use.
‡9
1
|
919
|
|
|
‡a
longitudinalchangesintotalbrainvolumeinschizophreniarelationtosymptomseveritycognitionandantipsychoticmedication
‡A
Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication
‡9
1
|
919
|
|
|
‡a
longitudinalpopulationsubgroupsofcrpandriskofdepressioninthealspacbirthcohort
‡A
Longitudinal population subgroups of CRP and risk of depression in the ALSPAC birth cohort
‡9
1
|
919
|
|
|
‡a
longitudinalregionalbrainvolumelossinschizophreniarelationshiptoantipsychoticmedicationandchangeinsocialfunction
‡A
Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function
‡9
1
|
919
|
|
|
‡a
lowerprevalenceofpremorbidneurologicalillnessinafricancaribbeanthanwhitepsychoticpatientsinengland
‡A
Lower prevalence of pre-morbid neurological illness in African-Caribbean than White psychotic patients in England.
‡9
1
|
919
|
|
|
‡a
maternalseparationatbirthandschizophreniaalongtermfollowupofthefinnishchristmassealhomechildren
‡A
Maternal separation at birth and schizophrenia—a long-term follow-up of the Finnish Christmas Seal Home Children
‡9
1
|
919
|
|
|
‡a
measuringthebenefitsoftreatmentforpsychosisvalidityandresponsivenessoftheeq5d
‡A
Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D.
‡9
1
|
919
|
|
|
‡a
metaanalyticapproachestodeterminegenderdifferencesintheageincidencecharacteristicsofschizophreniaandrelatedpsychoses
‡A
Meta-analytic approaches to determine gender differences in the age-incidence characteristics of schizophrenia and related psychoses
‡9
1
|
919
|
|
|
‡a
migrationandmentalillness
‡A
Migration and mental illness
‡9
1
|
919
|
|
|
‡a
mindfulnessbasedprogrammesformentalhealthpromotioninadultsinnonclinicalsettingsprotocolofanindividualparticipantdatametaanalysisofrandomisedcontrolledtrials
‡A
Mindfulness-based programmes for mental health promotion in adults in non-clinical settings: protocol of an individual participant data meta-analysis of randomised controlled trials
‡9
1
|
919
|
|
|
‡a
minocyclinefornegativesymptomsofschizophreniaandpossiblemechanisticactionsthebeneminrct
‡A
Minocycline for negative symptoms of schizophrenia and possible mechanistic actions: the BeneMin RCT
‡9
1
|
919
|
|
|
‡a
minorphysicalanomaliesacrossethnicgroupsina1episodepsychosissample
‡A
Minor physical anomalies across ethnic groups in a first episode psychosis sample
‡9
1
|
919
|
|
|
‡a
minorphysicalanomaliesinpatientswith1episodepsychosistheirfrequencyanddiagnosticspecificity
‡A
Minor physical anomalies in patients with first-episode psychosis: their frequency and diagnostic specificity.
‡9
1
|
919
|
|
|
‡a
minorphysicalanomaliesinpsychosesassociationswithclinicalandputativeaetiologicalvariables
‡A
Minor physical anomalies in psychoses: associations with clinical and putative aetiological variables
‡9
1
|
919
|
|
|
‡a
minorphysicalanomaliesinschizophreniaisageaconfoundingfactor
‡A
Minor physical anomalies in schizophrenia: is age a confounding factor?
‡9
1
|
919
|
|
|
‡a
modafinileffectsoncognitionandemotioninschizophreniaanditsneurochemicalmodulationinthebrain
‡A
Modafinil effects on cognition and emotion in schizophrenia and its neurochemical modulation in the brain
‡9
1
|
943
|
|
|
‡a
196x
‡A
1966
‡9
3
|
943
|
|
|
‡a
201x
‡A
2018
‡9
2
|
946
|
|
|
‡a
b
‡9
1
|
996
|
|
|
‡2
BIBSYS|14020423
|
996
|
|
|
‡2
J9U|987007381269505171
|
996
|
|
|
‡2
DBC|87097991139758
|
996
|
|
|
‡2
NTA|071957367
|
996
|
|
|
‡2
SUDOC|268120609
|
996
|
|
|
‡2
NKC|utb2011655784
|
996
|
|
|
‡2
BIBSYS|90200404
|
996
|
|
|
‡2
BIBSYS|90408808
|
996
|
|
|
‡2
NII|DA00244978
|
996
|
|
|
‡2
CAOONL|ncf10583625
|
996
|
|
|
‡2
NII|DA16103829
|
996
|
|
|
‡2
BLBNB|000252049
|
996
|
|
|
‡2
J9U|987009441229605171
|
996
|
|
|
‡2
DNB|115797094X
|
996
|
|
|
‡2
RERO|A000095391
|
996
|
|
|
‡2
NII|DA05275196
|
996
|
|
|
‡2
LC|n 2017061240
|
996
|
|
|
‡2
W2Z|1642068411609
|
996
|
|
|
‡2
NII|DA01916641
|
996
|
|
|
‡2
CAOONL|ncf10007018
|
996
|
|
|
‡2
NDL|001193147
|
996
|
|
|
‡2
RERO|A025765384
|
996
|
|
|
‡2
BIBSYS|90817366
|
996
|
|
|
‡2
J9U|987007330376605171
|
996
|
|
|
‡2
NDL|00444892
|
996
|
|
|
‡2
NUKAT|n 2011061525
|
996
|
|
|
‡2
ISNI|0000000023557216
|
996
|
|
|
‡2
NTA|144025620
|
996
|
|
|
‡2
LC|no2014075627
|
996
|
|
|
‡2
LC|no2006040775
|
996
|
|
|
‡2
ISNI|0000000496848101
|
996
|
|
|
‡2
NTA|073617261
|
996
|
|
|
‡2
SUDOC|179427830
|
996
|
|
|
‡2
NUKAT|n 2018086274
|
996
|
|
|
‡2
BNF|17843749
|
996
|
|
|
‡2
SUDOC|169882500
|
996
|
|
|
‡2
DNB|105405083X
|
996
|
|
|
‡2
NII|DA18135032
|
996
|
|
|
‡2
LC|n 85341429
|
996
|
|
|
‡2
ISNI|0000000442508881
|
996
|
|
|
‡2
RERO|A006427261
|
996
|
|
|
‡2
NDL|01145270
|
996
|
|
|
‡2
ISNI|0000000032650746
|
996
|
|
|
‡2
NTA|314249656
|
996
|
|
|
‡2
LC|no2019179939
|
996
|
|
|
‡2
LC|no2024026537
|
996
|
|
|
‡2
BIBSYS|10035374
|
996
|
|
|
‡2
ISNI|0000000506047499
|
996
|
|
|
‡2
LC|no2001045617
|
996
|
|
|
‡2
ISNI|0000000031749031
|
996
|
|
|
‡2
BNF|16181674
|
996
|
|
|
‡2
J9U|987007323771505171
|
996
|
|
|
‡2
ISNI|0000000001930518
|
996
|
|
|
‡2
PLWABN|9813658561805606
|
996
|
|
|
‡2
NDL|00919226
|
996
|
|
|
‡2
SUDOC|070986185
|
996
|
|
|
‡2
LC|n 00122035
|
996
|
|
|
‡2
NII|DA05091193
|
996
|
|
|
‡2
NUKAT|n 2007133076
|
996
|
|
|
‡2
DBC|87097946820401
|
996
|
|
|
‡2
BIBSYS|9044808
|
996
|
|
|
‡2
ISNI|000000047689037X
|
996
|
|
|
‡2
DNB|123749995X
|
996
|
|
|
‡2
SUDOC|056892802
|
996
|
|
|
‡2
CAOONL|ncf10366291
|
996
|
|
|
‡2
LNB|LNC10-000073522
|
996
|
|
|
‡2
NUKAT|n 2008133132
|
996
|
|
|
‡2
ISNI|0000000485894428
|
996
|
|
|
‡2
SUDOC|195393600
|
996
|
|
|
‡2
NII|DA02395147
|
996
|
|
|
‡2
J9U|987007450325705171
|
996
|
|
|
‡2
LC|n 2016056610
|
996
|
|
|
‡2
DNB|117545236X
|
996
|
|
|
‡2
ISNI|0000000389037856
|
996
|
|
|
‡2
BIBSYS|90160819
|
996
|
|
|
‡2
BIBSYS|90604133
|
996
|
|
|
‡2
LC|no2015080497
|
996
|
|
|
‡2
NTA|073644862
|
996
|
|
|
‡2
DNB|1254883371
|
996
|
|
|
‡2
SUDOC|257878459
|
996
|
|
|
‡2
ISNI|0000000067605822
|
996
|
|
|
‡2
LC|no 96042000
|
996
|
|
|
‡2
NII|DA14681766
|
996
|
|
|
‡2
PLWABN|9810578623205606
|
996
|
|
|
‡2
NUKAT|n 2007003287
|
996
|
|
|
‡2
DNB|1132099900
|
996
|
|
|
‡2
CAOONL|ncf10019517
|
996
|
|
|
‡2
NSK|000494934
|
996
|
|
|
‡2
SUDOC|251635031
|
996
|
|
|
‡2
ISNI|0000000075034724
|
996
|
|
|
‡2
LC|n 81122228
|
996
|
|
|
‡2
NDL|00469090
|
996
|
|
|
‡2
ISNI|0000000493355512
|
996
|
|
|
‡2
LC|no2017155140
|
996
|
|
|
‡2
LC|n 88282197
|
996
|
|
|
‡2
NSK|000467999
|
996
|
|
|
‡2
ISNI|0000000082421052
|
996
|
|
|
‡2
ISNI|0000000367061345
|
996
|
|
|
‡2
ISNI|0000000116884080
|
996
|
|
|
‡2
DNB|170026450
|
996
|
|
|
‡2
LC|nb2017007298
|
996
|
|
|
‡2
DNB|1158152507
|
996
|
|
|
‡2
BIBSYS|90366882
|
996
|
|
|
‡2
ISNI|0000000383359918
|
996
|
|
|
‡2
RERO|A013616273
|
996
|
|
|
‡2
XA|1388
|
996
|
|
|
‡2
RERO|A012853430
|
996
|
|
|
‡2
NTA|305642553
|
996
|
|
|
‡2
DNB|1114693847
|
996
|
|
|
‡2
BNC|981058511210806706
|
996
|
|
|
‡2
NII|DA07093666
|
996
|
|
|
‡2
DNB|13618989X
|
996
|
|
|
‡2
NTA|071490302
|
996
|
|
|
‡2
LC|no2022001557
|
996
|
|
|
‡2
LC|n 83027235
|
996
|
|
|
‡2
SUDOC|240191889
|
996
|
|
|
‡2
ISNI|0000000374569980
|
996
|
|
|
‡2
SUDOC|273585355
|
996
|
|
|
‡2
LC|n 85170927
|
996
|
|
|
‡2
BIBSYS|97020587
|
996
|
|
|
‡2
SELIBR|371711
|
996
|
|
|
‡2
BIBSYS|90805376
|
996
|
|
|
‡2
NUKAT|n 2009137512
|
996
|
|
|
‡2
NSK|000118846
|
996
|
|
|
‡2
NTA|068329547
|
996
|
|
|
‡2
LC|nb2022008717
|
996
|
|
|
‡2
J9U|987007338259605171
|
996
|
|
|
‡2
LC|n 80082814
|
996
|
|
|
‡2
LC|n 88044993
|
996
|
|
|
‡2
ISNI|0000000076932956
|
996
|
|
|
‡2
NSK|000251524
|
996
|
|
|
‡2
CAOONL|ncf11235511
|
996
|
|
|
‡2
LC|no2012021537
|
996
|
|
|
‡2
ISNI|0000000052872557
|
996
|
|
|
‡2
NUKAT|n 2008127436
|
996
|
|
|
‡2
RERO|A003944102
|
996
|
|
|
‡2
LC|n 78062681
|
996
|
|
|
‡2
BIBSYS|90219941
|
996
|
|
|
‡2
BIBSYS|3081460
|
996
|
|
|
‡2
ISNI|0000000073776265
|
996
|
|
|
‡2
NII|DA03375021
|
996
|
|
|
‡2
LC|nb2018011462
|
996
|
|
|
‡2
PLWABN|9810632275705606
|
996
|
|
|
‡2
ISNI|0000000039866240
|
996
|
|
|
‡2
ISNI|0000000403465815
|
996
|
|
|
‡2
LC|n 86844909
|
996
|
|
|
‡2
RERO|A003430025
|
996
|
|
|
‡2
RERO|A003430024
|
996
|
|
|
‡2
LC|n 83210727
|
996
|
|
|
‡2
RERO|A003430026
|
996
|
|
|
‡2
RERO|A003430021
|
996
|
|
|
‡2
RERO|A003430020
|
996
|
|
|
‡2
RERO|A003430023
|
996
|
|
|
‡2
RERO|A003430022
|
996
|
|
|
‡2
BIBSYS|90501991
|
996
|
|
|
‡2
BNF|15868260
|
996
|
|
|
‡2
NII|DA12529319
|
996
|
|
|
‡2
PLWABN|9810563118305606
|
996
|
|
|
‡2
ISNI|000000043467234X
|
996
|
|
|
‡2
BNF|15678494
|
996
|
|
|
‡2
SUDOC|277348439
|
996
|
|
|
‡2
LC|n 2020035857
|
996
|
|
|
‡2
B2Q|0001598121
|
996
|
|
|
‡2
BNF|12368443
|
996
|
|
|
‡2
RERO|A012514363
|
996
|
|
|
‡2
LC|n 92122471
|
996
|
|
|
‡2
J9U|987007366026505171
|
996
|
|
|
‡2
NII|DA01258978
|
996
|
|
|
‡2
ISNI|000000049686921X
|
996
|
|
|
‡2
J9U|987007449272605171
|
996
|
|
|
‡2
SUDOC|256789878
|
996
|
|
|
‡2
PLWABN|9814255918605606
|
996
|
|
|
‡2
ISNI|0000000408721494
|
996
|
|
|
‡2
LC|n 97060719
|
996
|
|
|
‡2
NII|DA0747504X
|
996
|
|
|
‡2
SIMACOB|194333539
|
996
|
|
|
‡2
LC|nb2006002125
|
996
|
|
|
‡2
SUDOC|074217976
|
996
|
|
|
‡2
LC|n 90630984
|
996
|
|
|
‡2
PLWABN|9810641764905606
|
996
|
|
|
‡2
SUDOC|189591811
|
996
|
|
|
‡2
NII|DA05589208
|
996
|
|
|
‡2
BNF|16919030
|
996
|
|
|
‡2
BIBSYS|14065646
|
996
|
|
|
‡2
DNB|1011623552
|
996
|
|
|
‡2
SUDOC|274025639
|
996
|
|
|
‡2
SUDOC|115075542
|
996
|
|
|
‡2
LC|n 83038540
|
996
|
|
|
‡2
LC|n 80086589
|
996
|
|
|
‡2
J9U|987007378722905171
|
996
|
|
|
‡2
ISNI|0000000424675029
|
996
|
|
|
‡2
LC|nb2018005198
|
996
|
|
|
‡2
NUKAT|n 2014093553
|
996
|
|
|
‡2
BIBSYS|98030108
|
996
|
|
|
‡2
BNF|17889640
|
996
|
|
|
‡2
LNB|LNC10-000297697
|
996
|
|
|
‡2
ISNI|0000000027161294
|
996
|
|
|
‡2
NUKAT|n 97028467
|
996
|
|
|
‡2
CAOONL|ncf10136140
|
996
|
|
|
‡2
BIBSYS|97004126
|
996
|
|
|
‡2
CAOONL|ncf11162465
|
996
|
|
|
‡2
SUDOC|272304549
|
996
|
|
|
‡2
SUDOC|147133025
|
996
|
|
|
‡2
LC|no 98017359
|
996
|
|
|
‡2
DNB|1158133545
|
996
|
|
|
‡2
ISNI|000000002946116X
|
996
|
|
|
‡2
NUKAT|n 2006105780
|
996
|
|
|
‡2
LC|n 84238708
|
996
|
|
|
‡2
CAOONL|ncf11910907
|
996
|
|
|
‡2
SUDOC|261690612
|
996
|
|
|
‡2
LC|n 85366108
|
996
|
|
|
‡2
NII|DA19381657
|
996
|
|
|
‡2
BNF|12090625
|
996
|
|
|
‡2
PLWABN|9810559458105606
|
996
|
|
|
‡2
NUKAT|n 01717286
|
996
|
|
|
‡2
J9U|987007434989905171
|
996
|
|
|
‡2
BIBSYS|2093202
|
996
|
|
|
‡2
DBC|87097969538894
|
996
|
|
|
‡2
LC|n 85152443
|
996
|
|
|
‡2
ICCU|PARV403638
|
996
|
|
|
‡2
ISNI|0000000395486826
|
996
|
|
|
‡2
DNB|121966143
|
996
|
|
|
‡2
BIBSYS|90322516
|
996
|
|
|
‡2
LC|no 00019775
|
996
|
|
|
‡2
RERO|A003015896
|
996
|
|
|
‡2
LC|n 2012072674
|
996
|
|
|
‡2
NII|DA05900698
|
996
|
|
|
‡2
BIBSYS|1560455415803
|
996
|
|
|
‡2
RERO|A012425776
|
996
|
|
|
‡2
NII|DA06014223
|
996
|
|
|
‡2
LC|no 97006732
|
996
|
|
|
‡2
ISNI|0000000067568486
|
996
|
|
|
‡2
BIBSYS|90913562
|
996
|
|
|
‡2
BNF|12404007
|
996
|
|
|
‡2
BAV|495_22896
|
996
|
|
|
‡2
PTBNP|211810
|
996
|
|
|
‡2
BIBSYS|8023581
|
996
|
|
|
‡2
NII|DA01170094
|
996
|
|
|
‡2
ISNI|0000000372264200
|
996
|
|
|
‡2
LC|n 2010010486
|
996
|
|
|
‡2
NII|DA04424643
|
996
|
|
|
‡2
ISNI|0000000117267754
|
996
|
|
|
‡2
BNF|17965838
|
996
|
|
|
‡2
LIH|LNB:BNT_k_;=B_l_
|
996
|
|
|
‡2
BIBSYS|14050305
|
996
|
|
|
‡2
SUDOC|052480852
|
996
|
|
|
‡2
NDL|032862970
|
996
|
|
|
‡2
NTA|068736746
|
996
|
|
|
‡2
BNC|981058524594306706
|
996
|
|
|
‡2
J9U|987007387395405171
|
997
|
|
|
‡a
1960 0 lived 0000 0
‡9
1
|
998
|
|
|
‡a
Jones, Peter Brian
‡2
NUKAT|n 2007133076
‡3
suggested
‡3
viafid
|
998
|
|
|
‡a
Jones, Peter B.
‡2
BIBSYS|4091608
‡3
viafid
|
998
|
|
|
‡a
Jones, Peter B.
‡q
(Peter Brian),
‡2
LC|no2003084028
‡3
suggested
‡3
title: (0.89, 'europeanschizophreniaoutpatienthealthoutcomessohostudy', 'europeanschizophreniaoutpatienthealthoutcomessohostudyrationalemethodsandrecruitment')
|
998
|
|
|
‡a
Jones, Peter B.
‡q
(Peter Brian),
‡2
J9U|987007370891405171
‡3
suggested
‡3
title: (0.89, 'europeanschizophreniaoutpatienthealthoutcomessohostudy', 'europeanschizophreniaoutpatienthealthoutcomessohostudyrationalemethodsandrecruitment')
|
998
|
|
|
‡a
جونز، بيتر ب.،
‡2
J9U|987007370891405171
‡3
suggested
‡3
title: (0.89, 'europeanschizophreniaoutpatienthealthoutcomessohostudy', 'europeanschizophreniaoutpatienthealthoutcomessohostudyrationalemethodsandrecruitment')
|
998
|
|
|
‡a
Jones, Peter B
‡2
ISNI|0000000119535791
‡3
suggested
|
998
|
|
|
‡a
Jones, Peter B.
‡2
ISNI|0000000119535791
‡3
suggested
|
998
|
|
|
‡a
Jones, Peter Brian
‡2
ISNI|0000000119535791
‡3
suggested
|
998
|
|
|
‡a
Jones, Peter B.
‡2
ISNI|0000000119535791
‡3
suggested
|
998
|
|
|
‡a
Jones, Peter B.
‡2
DNB|1011623552
‡3
suggested
|
998
|
|
|
‡a
Jones, Peter B.
‡2
SUDOC|070986185
‡3
suggested
|
998
|
|
|
‡a
Jones, Peter Brian
‡2
PLWABN|9810563118305606
‡3
viafid
|
998
|
|
|
‡a
Jones, Peter B.
‡2
SZ|1011623552
‡3
partial date, partial title
|
998
|
|
|
‡a
Jones, Peter B.
‡q
(Peter Brian),
‡2
CAOONL|ncf12118371
‡3
title: (0.89, 'europeanschizophreniaoutpatienthealthoutcomessohostudy', 'europeanschizophreniaoutpatienthealthoutcomessohostudyrationalemethodsandrecruitment')
|